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“How lucky we are to live in this time, the first moment in human history when we are, 
 in fact, visiting other worlds.” 
                                                                                                         - Carl Sagan 

  1 
ABSTRACT 
 
The goal of regenerative medicine is to be able to help the body to replace worn-out cells 
and tissues. To achieve this goal, one approach being pursued today is to recruit and boost 
the body’s own mechanisms for cell replacement. In the brain, this approach is perhaps 
more challenging than in many other organs because the brain’s own ability to replace 
neurons is almost non-existent. Therefore, an alternative strategy is to genetically 
reprogram support cells in the living brain directly into neurons, or into progenitor cells 
which in turn would produce neurons. For such a strategy to work, a first step is to identify 
a cell type in the brain that has the capacity to act as a source for neurons. 
 
This thesis describes work that shows for the first time that astrocytes, one of the most 
abundant cell types in the brain, can generate neurons in vivo under certain circumstances 
and in certain brain regions. Thus, astrocytes represent a potential reservoir for new 
neurons, whose neurogenic capacity might be recruited to improve brain repair.  
 
In Paper I, we describe the finding that some astrocytes generate neurons in response to 
stroke in the striatum of mice. We found that the neurogenic capacity of these astrocytes 
was under control of the Notch signaling pathway. By manipulating this pathway 
experimentally, we could activate the neurogenic program of these astrocytes even in the 
absence of stroke. Yet, not all astrocytes generated neurons. In fact, outside the striatum, 
most of them did not do so, neither after stroke nor after Notch manipulation.  
 
In Paper II, we therefore used single-cell RNA sequencing to better understand how 
astrocytes respond to Notch manipulation and why this does not induce all astrocytes to 
undergo neurogenesis. We found that even astrocytes that do not generate neurons in fact 
initiate early steps of neurogenesis. However, they halt their lineage progression 
immediately before undergoing transit-amplifying divisions. In the striatum, exposure to a 
mitogen pushed such halted astrocytes into transit-amplifying divisions, and our results 
suggest that similar strategies could work also outside the striatum, given the right stimulus.  
 
In Paper III, we asked whether stroke-induced striatal neurogenesis occurs also in humans. 
For this, we used radiocarbon dating to assess the age of striatal neurons isolated from post-
mortem samples of stroke patients. We found that the stroke-injured striatum contains a 
higher proportion of young neurons than the non-injured striatum of the same subjects. This 
could be explained either by neurogenesis or selective death of old neurons. Each of these 
possibilities would represent an interesting and previously undescribed biological scenario.   
 
The work in these three papers suggests that endogenous brain cells exist whose neurogenic 
properties could be recruited to improve brain repair. However, one additional challenge 
with neuronal replacement strategies is that the great diversity of neurons in the brain is still 
incompletely characterized. Before any cell replacement interventions can be undertaken, 
the cell composition in the healthy brain must be known. In Paper IV, we describe a new 
method for performing RNA sequencing on intact tissue sections with retained spatial 
information. This technique, dubbed spatial transcriptomics, is useful for answering 
fundamental biological questions about cell distribution and gene expression. In addition, it 
could provide valuable information for disease diagnostics. In summary, the work presented 
in this thesis provides information that may prove crucial for bringing neuronal replacement 
strategies closer to the clinic.  
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1 INTRODUCTION 
 
The brain is not good at repairing itself. This is seen clearly after a stroke. Only minutes after 
a blood clot or bleeding has obstructed blood flow to the brain, neurons start dying from a 
lack of oxygen (1). These neurons will never be replaced. Instead, the healing brain seals the 
lesion with a scar, a scar that does not function at all like normal brain tissue. 
Stroke is the second most common cause of death in the world, after ischemic heart disease 
(224). But even among survivors, stroke often leads to severe disability and reduced quality 
of life. As if that was not enough, stroke and other brain disorders caused by neuronal loss 
place a huge economic burden on society. Such disorders, like Parkinson’s disease, 
Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and traumatic brain injury, have 
direct health care costs amounting to around €77 billion per year in Europe, which 
corresponds to 6% of all direct health care costs (2). This large economic burden comes 
partly from the disability and loss of productiveness caused by these disorders. Partly, too, it 
derives from the fact that brain ailments often cannot be cured but require lifelong treatment. 
For these reasons, any new therapy capable of replacing lost neurons and restoring brain 
function, even if only partially, would have a tremendous positive impact, both on individuals 
and on society.  
About two decades ago, it became clear that a few regions of the adult brain contain neural 
stem cells that continuously produce neurons throughout life. Initially, there was hope that 
this biological phenomenon represented a hitherto undiscovered mechanism for brain repair. 
Perhaps these stem cells were capable of supplying the whole brain with replacement 
neurons, if only their output could be boosted. However, the more adult neurogenesis has 
been studied, the more it has become clear that newborn neurons are not primarily made for 
brain repair; instead, they play an important role for some very specialized functions in the 
healthy brain. The brain will likely not turn into a regenerative organ simply by mobilizing 
these neural stem cells. This means that other ways must be devised with which to produce 
new cells for the injured brain. Today, one approach in particular is being vigorously pursued 
experimentally, namely to genetically engineer support cells inside the living brain, either 
turning them directly into neurons or first into progenitor cells that in turn generate neurons.  
This thesis describes work that represents a small step in this direction – the discovery that 
astrocytes, an abundant type of support cell in the brain, can generate neurons under certain 
circumstances in mice. We found that this neurogenic capacity of astrocytes could in some 
brain regions even be activated in healthy mice through genetic manipulation. This finding 
introduces the possibility that astrocytes may in the future be used as a source for new 
neurons.  
This work should be understood within the broader context of regenerative medicine. In this 
rapidly advancing research field, the long-term goal is to be able to replace worn-out cells, 
tissues and organs throughout the body through biological engineering. However, for this to 
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become reality, it is necessary to first develop a deep understanding of the mechanisms that 
govern how the cells in our body normally acquire and maintain their identity, and how our 
organs are kept functional throughout life in both health and disease. 
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2 CELL REPLACEMENT AND TISSUE REPAIR 
 
2.1  THE BODY PLAN 
Consider the process by which a single cell, the fertilized egg, gives rise to a fully formed 
body. Through this process – embryo development – hundreds, then millions and finally 
trillions of dividing cells interact to form highly structured tissues and organs. This happens 
through an extraordinarily complex process of self-organization: Genetic programs, written in 
DNA, unfold in every cell at the same time; sequences of genetic subroutines are executed to 
establish cell identity step by step. All cells may be identical on the genome level, but in the 
early embryo, minuscule fluctuations may be enough to set even neighboring cells on 
different paths. Through switch-like genetic circuits, small differences between cells are 
amplified. Molecules secreted by the jostling and proliferating cells establish the patterning 
signals that orchestrate the realization of the body plan. 
The cells that make up the early embryo have the potential to generate any cell type in the 
body. These are embryonic stem cells. However, as development proceeds, the potential of 
these cells gradually diminishes as they divide and differentiate. As the body takes shape, 
many organs are seeded with what will later become adult stem cells, whose potential is 
restricted to generating only the specialized cell types of their own organs.  
The term stem cell is loosely defined but is generally used to describe cells that display two 
cardinal properties: the potential to generate multiple cell types, and the capacity to self-
renew for an indefinite number of cell divisions. Much of the regenerative potential in adult 
organs lies in these stem cells. Therefore, strategies to artificially enhance the regenerative 
potential of the human body might work by recruiting and boosting the output of such cells. 
For this reason, characterizing the processes by which the body normally maintains proper 
cell numbers is of utmost importance. 
 
2.2 CELL REPLACEMENT IN THE HEALTHY ADULT BODY 
All tissues in the adult body are exposed to some level of wear and tear, and the body 
therefore needs mechanisms to replace cells that are continuously being lost (Figure 1). In 
some tissues, the level of cell loss is low or moderate. In these tissues, differentiated cells can 
often maintain their own numbers through slow but steady cell replication. Examples of cell 
types that use this mode of renewal include epithelial cells in the lungs and kidneys (3, 4), 
islet cells in the pancreas (5), microglia in the brain (6), hepatocytes in the liver (7), and likely 
cardiomyocytes in the heart (8). In other tissues, however, the extent of cell loss is so great 
that special mechanisms have needed to evolve just to be able to maintain the number of cells 
required for normal function. For example, the bone marrow generates new blood cells at the 
staggering rate of 200 billion cells per day, which is equivalent to the number of cells in the  
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çFigure 1. Cell turnover in the adult mammalian body. Examples of cell turnover in adult organs 
and tissues are shown. For some cell types, the organisms from which evidence derives are specified 
in parentheses. 
 
entire human brain (though red blood cells are smaller) and corresponds to about 1% of all 
blood cells. The situation is similar in the skin and intestinal epithelium, tissues that 
experience a tremendous amount of abrasion as a result of normal life. In tissues like these, 
the extreme cell production rates are powered not by the duplication of differentiated cells, 
but by adult stem cells. When an adult stem cell divides, it can generate one copy of itself as 
well as one daughter cell termed a short-term stem cell or transit-amplifying cell. This latter 
cell, in turn, initiates a rapid series of divisions that results in tens of differentiated cells being 
produced at once, consuming the transit-amplifying cells in the process (Figure 2). Through 
this process of asymmetric cell division, each stem cell can generate many new cells in one 
go and avoid depletion of the stem cell pool. 
 
 
Figure 2. Modes of cell generation in 
the adult body. Tissues with low to 
medium levels of cell replacement 
often rely on the simple duplication of 
pre-existing cells (A). Tissues with 
very rapid cell turnover rely on 
dedicated stem cells, which generate 
differentiated cells via highly 
proliferative transit-amplifying cells 
(B). Figure adapted from (9) with 
permission. 
 
 
Why have tissues with the highest level of cell turnover evolved this special setup with stem 
cells? The answer is that it minimizes DNA damage. Every time a cell divides and copies its 
genome, a few copying errors occur randomly in its DNA. Over the course of many divisions, 
such mutations accumulate and increase the risk that a cell will transform into a cancer cell 
that starts dividing uncontrollably. By creating a hierarchy of proliferating transit-amplifying 
cells, stem cells can generate many differentiated cells at once while at the same time 
minimizing the proliferative burden they place on themselves. In this way, tissues like the 
bone marrow, skin and intestinal epithelium can continue to produce new cells and maintain 
tissue homeostasis throughout life.  
Nonetheless, despite this protective mechanism our tissues and organs become less capable of 
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producing new cells as we age. This decline generally starts already around the age of 30 for 
some tissues like skeletal muscle, hair, skin, and bone (10). That the decline starts so early 
likely reflects the fact that we humans rarely used to live long beyond our 40s or 50s when 
our species first evolved; strong evolutionary pressure may not have existed for keeping 
tissues healthy for many decades more than that. Age-related decline is probably caused 
partly by the slow but inevitable accumulation of mutations in stem cells. For example, 
hematopoietic stem cells acquire on the order of 10 mutations per year (11). During normal 
aging, each such stem cell will therefore accumulate hundreds of mutations, scattered more or 
less randomly throughout the genome. Most of these mutations will have no detectable effect 
on a cell, and of those that do, most will probably lead to reduced proliferative capacity of the 
cell. This mutational burden could underlie the decreased capacity to maintain normal cell 
replacement with age. 
Though most mutations are detrimental to a cell’s proliferative capacity, some mutations will, 
purely by chance, endow cells with an increased tendency to divide and survive. In the 
natural selection-like environment among neighboring stem cells, such mutations give cells a 
selective advantage. With time, cell clones with the highest proliferative advantage will tend 
to take over and dominate the stem cell pool. This process, whereby most stem cells decrease 
their competitiveness but a few increase theirs, is believed to be the cause for an observed 
decline in stem cell diversity with age (12). But what is worse, it may with time cause cells to 
develop another age-related phenomenon: cancer. This has been demonstrated in the skin 
(13). With age, normal sun-exposed skin develops into a patchwork of dominating cell 
clones. Strikingly, people in their 50s-70s carry mutations in TP53, the most commonly 
mutated gene among all cancers, in 3-5% of all their skin cells. This corresponds to about 10 
cell clones with mutated TP53 per cm2 of normal skin. All in all, aged skin contains hundreds 
of evolving clones per cm2, each clone consisting of cells carrying thousands of mutations 
(13). These findings are sobering and suggest that over the course of evolution, tissues with 
very high cell turnover must have been under high selective pressure to evolve mechanisms 
that minimize the DNA damage associated with cell division. The hierarchies of stem cells 
and transit-amplifying cells found in tissues like skin, blood and intestine likely represent 
such a protective mechanism. 
Taken together, the mechanisms that replace cells and maintain tissue homeostasis work best 
for only a few decades in humans, and after that appear more and more unregulated and 
subject to adverse events. Interestingly, however, one aspect of healthy stem cell maintenance 
might in the foreseeable future become a target of pharmaceutical manipulation. Stem cells 
are not only regulated by cell-intrinsic properties but, to an equal extent, also by their 
extracellular environment. Recent research is showing that the age-related decline of stem 
cell function derives partly from changes to the extracellular environment. Intriguingly, at 
least some of these changes may be reversible. In an experiment termed heterochronic 
parabiosis, researchers have surgically joined the blood vessels of a young and an old mouse, 
such that the two mice are exposed to each other’s blood. These experiments have shown that 
stem cells in young mice show functional decline when exposed to old blood; conversely, 
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when the researchers studied stem cells in brain and muscle of old mice, they found that these 
cells increased their proliferation or regenerative capacity when exposed to young blood (12). 
Now, researchers are trying to identify the factors responsible for this remarkable effect. One 
emerging conclusion is that molecules associated with inflammation may be culprits. Many 
such molecules are more highly concentrated in aged blood, reflecting the fact that diffuse, 
low-grade inflammation is often present in aged individuals (14). Such inflammatory factors 
may impair normal stem cell function. For example, CCL11, a cytokine, decreases 
hippocampal neurogenesis if infused into the blood of young mice (15). Conversely, 
oxytocin, TIMP2 and, possibly, GDF11 are enriched in young blood and can increase the 
function of certain aged tissues in mice (16–21). The long-term goal of this research is to 
identify mechanisms and molecules that could be manipulated to reverse the age-related 
decline in homeostasis seen in most organs. 
The mechanisms described here are responsible for the cell replacement that takes place in 
the healthy adult. However, after injury and in disease, increased cell loss and disruption of 
normal tissue architecture can often place much higher demands on our body’s reparative 
capacity. 
 
2.3 CELL REPLACEMENT AND TISSUE REPAIR AFTER INJURY 
The same mechanisms that serve to replenish cell numbers in healthy tissues are also 
important for replacing cells lost to injury or disease (see Figure 1). After liver injury, for 
example, proper cell numbers are restored through the replication of surviving, mature 
hepatocytes (7). In epithelia, such as those in the lungs or kidneys, mature cells successfully 
repopulate the damaged epithelium through simple cell duplication, at least if the injury is not 
too severe (3, 4). In a corresponding fashion, tissues where cell replacement normally 
depends on adult stem cells, the high proliferative capacity of these stem cells soon heal 
minor abrasions or limited cell loss. For example, even after heavy bleeding, hematopoietic 
stem cells soon restore normal blood cell numbers. 
In addition to these mechanisms, however, injury can trigger modes of cell replacement that 
are not seen in healthy tissue. If the need for cells is greater than what normal mechanisms of 
replacement can handle, many tissues recruit dormant stem cells, cells that normally do not 
display any proclivity for cell replacement. Such cells are sometimes called facultative stem 
cells, the word facultative being defined in biology as “capable of but not restricted to a 
particular function or mode of life” (225). Thus, a facultative stem cell only displays its 
regenerative potential in the context of injury. In skeletal muscle, satellite cells have this role, 
reacting to muscle injury by entering the cell cycle and replacing dead myocytes (22). In 
intact muscle, however, they appear to do nothing else than to lie in wait, having no obvious 
role in normal muscle function. Similarly, the intestinal epithelium harbors “+4” cells, so 
named for their position as the fourth cells from the bottom of intestinal crypts. These, too, 
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remain dormant most of the time, but are activated by severe lesions to replace the Lgr5+ 
stem cells that normally replenish the intestinal epithelium (23).  
Facultative stem cells are, however, not always silent bystanders in the absence of injury. 
Often, they lead double lives, having other, unrelated functions in the healthy organ. For 
example, club cells in lung epithelium, or tubular epithelial cells in kidney, normally have 
important roles for tissue function, but after severe injuries are able to dedifferentiate and 
generate also some other cell types (3, 24). In skin, stem cells whose normal lifestyle is 
restricted to maintaining either hair follicles, sweat glands or sebaceous glands, react to injury 
by expanding their potential, becoming able to generate also intrafollicular epidermis (25). 
Thus, the cells involved in injury repair have adopted a wide variety of lifestyles. In this 
thesis, one main finding is the identification of astrocytes as facultative stem cells in the 
mouse brain, being activated by stroke to generate new neurons. 
Ideally, a tissue’s response to injury should be to regenerate itself so effectively that it 
becomes both morphologically and functionally equivalent to what it was before the injury. 
However, human tissues do not do this. In fact, injury repair in all mammals suffers from 
three major limitations. The first limitation is that many tissues lack the capacity to replace 
dead cells effectively. The heart and the brain are particularly bad at this. Most 
cardiomyocytes that perish during a heart attack are not replaced, and most neurons lost to 
stroke are never seen again. It is an interesting coincidence that the two organs with the worst 
cell replacement capacity in the body are also those whose failure kills the most people. As 
mentioned, the two leading causes of death in the world are ischemic heart disease and stroke. 
Perhaps because injuries here often lead to instant death, there has not been strong 
evolutionary pressure for survivors to develop effective repair mechanisms in these organs. 
The second limitation to mammalian injury repair is that lesions to almost all tissues result in 
the formation of a scar. A scar is a mesh of tough extracellular matrix and newly formed cells 
(26). On the one hand, scar formation serves to quickly seal a wound, re-establish tissue 
integrity, and contain damaging inflammation. This minimizes risk for secondary damage, 
which the sensitive region surrounding a lesion is susceptible to. On the other hand, scar 
tissue is not functionally equivalent to the tissue that was lost. Therefore, the function of a 
healed wound is often reduced compared to what it was before the injury. Scar tissue does 
not, for example, contribute to the beating of an injured heart. In the skin, scar tissue contains 
neither sweat glands, hair follicles nor sebaceous glands. And in the intestine, despite the high 
capacity for cell replacement in its epithelium, any wound that penetrates deeper than that 
will result in scar formation. This is seen, for example, in chronic inflammatory bowel 
disorders or after surgical intestinal ligation.  
The third limitation to injury repair in mammals is that only relatively small wounds can be 
repaired. If an entire limb is lost, say, or an eye or a kidney, these cannot be regrown. Once 
embryo development is complete, the body does not have the capacity to re-initiate the 
developmental programs responsible for organ patterning. The liver is an illustrative example. 
This organ has a remarkable capacity to replace lost cells. Even if as much as 75% of the liver 
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is lost, cells in the remaining part will proliferate until the liver has regained its original size 
(27). However, the shape of the liver will not be the same as before. If one of the liver’s two 
lobes is surgically removed, the regrown liver will contain only one very large lobe. Having 
now a new, altered shape, it will not be properly held in place by surrounding ligaments (7). 
Thus, the liver is capable of functional but not morphological regeneration.  
Therefore, injury repair in mammals is not true regeneration. Instead, the word regeneration 
could perhaps only properly be used to describe a tissue response that restores both form and 
function. There are animals where this happens. Among the vertebrates, none display this 
more spectacularly than the salamanders. This diverse and remarkable group of animals has 
been studied for their amazing regenerative properties since at least the 1700s, though only in 
the age of molecular biology have the underlying molecular mechanisms begun to be 
understood. At the end of the 1800s and beginning of the 1900s, the regenerative capacity of 
salamanders was extensively mapped through meticulous experiments, many of which would 
not be considered ethical today (226). For example, there are salamander species that can 
regrow their limbs and tail and regenerate organs such as the spinal cord, jaws, gills, liver, 
lungs, intestine, eye lens, heart, and brain. Not only are these organs regenerated in function, 
like the human liver, but also in form, and without scars. Limits exist, however, to their 
regenerative ability. There must be something left of an organ for it to regenerate. If an entire 
organ is removed, or if a limb is amputated at shoulder level, they will not grow back. 
Regeneration requires patterning signals that guide organ growth and cell proliferation, 
signals that are not properly established if too much of an organ or limb is missing. 
The study of salamander regeneration is fascinating, not only as a curiosity, but as an 
inspiration for what might one day be possible to achieve in humans, given sufficiently 
advanced tissue engineering technology. The cellular mechanisms that underlie regeneration 
in these species could in principle be artificially transferred to wound repair in humans. Part 
of the secret behind the regenerative capacity of these animals lies in their scarless wound 
healing. In salamanders, cells in a healing wound deposit much less extracellular matrix than 
in mammals; particularly noteworthy is a different composition of proteins like collagen. In 
addition, cells in a salamander wound site express matrix remodeling proteins that constantly 
re-sculpt and remove extracellular matrix, something that does not happen in mammals (26). 
But perhaps the most striking aspect of salamander regeneration is that lesioned forms a 
blastema, a mass of undifferentiated cells in which molecules secreted by spared nerves and 
skin establish a signaling center from which patterning signals emerge (26)*. These patterning 
signals guide proliferating cells to organize into the proper shape of that limb or organ. A 
blastema does not form around a wound site in adult mammals.  
                                                
* Incidentally, a blastema is analogous to the regenerative tissue in plants called callus, namely an 
unorganized mass of undifferentiated cells that forms over a plant wound and serves as the basis for 
regeneration. 
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Clearly, then, we mammals lack the regenerative capacity of salamanders. Many of our 
tissues do harbor a potential to replace lost cells, but after injuries where proper regeneration 
requires even the slightest bit of patterning, many tissues instead resort to scar formation. 
This observation prompts the question of whether mammalian cells are fundamentally 
incapable of mounting a regenerative response similar to that of salamanders, or whether our 
cells could in principle do it given the right stimuli.  
As a matter of fact, examples exist that give cause for optimism. The African spiny mouse 
(genus Acomys) has evolved a defense mechanism by which the entire skin on its back tears 
off completely if grabbed. It then quickly mounts a regenerative response to regrow all layers 
of the skin, including hair follicles and glands (28). In the same species, experimental wounds 
to the ear heal perfectly and without scar formation, through a process that involves the 
formation of a regenerative blastema.  
Even in humans, injuries can heal scarlessly in the fetus (29), demonstrating that this is 
possible in principle. Most spectacularly, though, is the fact that completely severed 
fingertips can grow back in children if the cut has been distal enough to spare the nail bed 
(30). This fascinating instance of true mammalian regeneration has been studied more closely 
in mice, which share this capacity (31). It turns out that fingertip regeneration in mammals 
happens through mechanisms that are very similar to limb regeneration in salamanders. Stem 
cells in the nail bed of the severed fingertip organize a signaling center, which serves to 
attract nerves. These, in turn, promote the outgrowth of a mesenchymal blastema, from which 
the fingertip regrows. 
Taken together, the wound healing capacity of humans is relatively poor, but on the positive 
side, our cells do not seem fundamentally incapable of mounting a much more effective 
regenerative response. It may be possible to achieve improved repair artificially, by tweaking 
the (admittedly very complex) environment of an injury site to mimic that of a perfectly 
regenerating wound. 
The long-term goal in regenerative medicine is to help the body to replace cell types, regrow 
tissues and even entire organs. It is inspiring and instructive to study the effectiveness by 
which these processes happen in some other animal species. Imitating these mechanisms in 
humans will not be an easy task, but may be possible. Nonetheless, there may be no other part 
of the body where the goal of tissue regeneration appears more daunting than the nervous 
system. Here, the sheer complexity of the tissue makes the whole idea of artificially enhanced 
regeneration seem outlandishly difficult to realize. 
 
2.4 REGENERATION IN THE NERVOUS SYSTEM 
As we have seen, the outcome of wound healing is determined by a tissue’s capacity for cell 
replacement, tendency for scar formation and, in severe cases, ability to establish patterning 
signals that guide re-acquisition of proper tissue architecture. All of these aspects are 
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important in the nervous system, too. However, due to the special architecture of the nervous 
system, imperfect wound healing has particularly severe consequences here. This is because 
neuronal function is completely determined by neuronal connections. 
The patterns by which neurons wire up to one another are largely established during brain 
development. The architecture of neuronal circuits determines which computations these 
circuits can perform – in other words, which behaviors they are capable of producing. 
Though some neurons project only locally, others extend their axons over very long distances 
– many centimeters or even a meter in the case of some of the neurons that innervate the legs. 
This means that the nervous system is not only susceptible to injuries that kill neurons 
outright, but also to lesions that only sever their projections.  
The nervous system can be subdivided into the central (brain and spinal cord) and peripheral 
nervous systems (nerves and neuronal aggregates outside the brain and spinal cord). These 
subdivisions have different developmental origins, and as we shall see, the way they respond 
to injury is dramatically different. 
 
2.4.1 Regeneration in the peripheral nervous system  
In all aspects of repair, the peripheral nervous system appears better than the central (Figure 
3). Neuronal projections – axons – provide an important example. These project through the 
body in bundles called nerves, each axon being wrapped in insulating myelin by Schwann 
cells. A nerve contains many axons. For example, the two sciatic nerves, which innervate the 
legs, are the body’s thickest. In rats, each contains about 27,000 axons (227). The human 
sciatic nerves, with their diameter of nearly 1 cm, have a cross-sectional area roughly 400 
times as big as those of the rat and thus contain many more axons.  
If a nerve in the peripheral nervous system gets transected, its axons can regrow to 
reinnervate their targets. As the distal, dead part of a severed axon is cleared by macrophages, 
the proximal stump begins to grow across the lesion site, aided by a bridge of 
dedifferentiating Schwann cells, fibroblasts, macrophages and blood vessels. Schwann cells 
distal to the injury reorganize themselves and form canals, secreting growth factors that guide 
the regrowing axons toward their targets (32), which grow at a rate of about 4 mm per day in 
rats (33). 
This process is remarkable; yet, it is not perfect. Not all axons reinnervate successfully. The 
slow rate at which axons regrow means that if one is severed very far from its target, it may 
take months to reach it. The further an axon needs to grow, and the more time it takes, the 
less likely reinnervation is to succeed (34). Moreover, a regrowing axon does not necessarily 
find its way back to exactly the same target it innervated prior to the injury. Among 
regrowing axons of motor neurons, for example, some axons succeed and others do not. The 
ones that do so reinnervate three to five times more muscle fibers than normal, masking the 
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Figure 3. Neurogenesis in the central and peripheral nervous system of mammals. Examples of 
neuronal cell turnover in the adult mammalian body. Evidence derives from studies in rodents unless 
otherwise specified. 
 
failure of many other axons (35). Notwithstanding these limitations, the fact that axonal 
regrowth does occur at all in the peripheral nervous system is striking.  
Even more noteworthy, perhaps, is that the neurons themselves in the peripheral nervous 
system can be replaced if they die. An example of this can be seen in the enteric nervous 
system. This subdivision of the peripheral nervous system runs as a neuronal meshwork along 
the entire esophagus, stomach and intestine, and to some degree functions independently of 
input from the brain and spinal cord. Embedded in the muscular layer and submucosa of the 
gastrointestinal tract, the bodies of neurons are aggregated in clusters called ganglia and 
plexuses, and consist of both sensory-, motor- and interneurons. Ganglia continuously lose 
neurons from apoptosis during healthy adult life, but constantly replace them through 
neurogenesis (36). In addition, one study showed that in response to a chemical injury, where 
a substantial amount of neurons were killed at once, dead neurons could be replaced (37). 
Such injury-induced neurogenesis has been demonstrated also in other subdivisions of the 
peripheral nervous system, like the dorsal root ganglia (38), trigeminal nerve ganglion (39), 
nodose ganglion (40) and olfactory epithelium (41, 42). 
Neuronal loss is not, however, the only trigger for adult neurogenesis in the peripheral 
nervous system. The olfactory epithelium displays continuous neurogenesis throughout 
adulthood (43). In addition, neurogenesis can be employed to correct disturbances in some 
homeostatic functions. The carotid body is a cluster of dopaminergic neuron-like glomus cells 
in the throat, which detect changes in oxygen and carbon dioxide. In response to a low-
oxygen environment, such as that during acclimatization to high altitudes, the carotid body 
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grows several times its normal size. This expansion is driven by the generation of new 
glomus cells (44). The carotid body is thus similar to the liver in that cell number is precisely 
tuned to match physiological need. 
How are these neurons made? In the peripheral nervous system, neurons are not the only cell 
types that exist. Myelinating Schwann cells and at least a handful of other cell types similar to 
the central nervous system’s astrocytes are present here. The emerging picture is that such 
glial cells serve as neuronal precursors. In the carotid body, new cells are generated by the 
GFAP-expressing sustentacular cells, via Nestin-expressing intermediate progenitor cells 
(44). In the dorsal root ganglia, trigeminal nerve ganglion and nodose ganglia, the astrocyte-
like satellite glial cells, expressing GFAP, Nestin and/or Pgp9.5 are the neuronal precursors 
(38–40), and in the olfactory epithelium, Lgr5+ globose basal cells have this role (45).  
In the enteric nervous system, the neuronal precursors are the enteric glial cells. Like satellite 
glial cells of peripheral ganglia, these are very similar to astrocytes, both in their marker 
profile (e.g. GFAP, Glutamine synthetase, Vimentin, S100β) (46), as well as morphology and 
ultrastructure (228, 229). They are, however, not identical to astrocytes. One subset expresses 
Sox10, for example. These Sox10+ cells are responsible for generating neurons in the 
developing enteric nervous system (37), a process to which immigrating Dhh+ Schwann cell 
progenitors also contribute in the early postnatal period (47). After birth, however, the Sox10+ 
cells switch from neurogenesis to gliogenesis and do not contribute to adult neurogenesis in 
the enteric nervous system. Instead, another subset of satellite glial cells, negative for Sox10 
but positive for Nestin, steps in and generates neurons during adulthood (36, 48). Still, the 
Sox10+ cells do not lose their neurogenic potential altogether. They can generate neurons in 
vitro if isolated and cultured (37). And after injury they reactivate their neurogenic potential 
and generate neurons in vivo (37). Thus, the enteric nervous system appears to have at least 
two subtypes of enteric glial cells with different roles in adult neurogenesis: The Nestin+ 
Sox10- cells, responsible for tissue homeostasis, and the Sox10+ cells, which in the adult only 
generate neurons after injury and thus represent facultative stem cells. Although the 
mechanism by which enteric neural stem cells generate neurons is not well characterized, it 
may be similar to that in the central nervous system and occur through transit-amplifying 
intermediates: Reports have described cells that express the proneural transcription factor 
Ascl1 (37) or microtubule-associated protein Dcx (48), just like developing neurons in the 
brain. It is not impossible, however, that enteric neurogenesis occurs through a different 
process whereby one stem cell generates only one neuron at a time. Exactly which types of 
neurons are born in adulthood, and exactly how they integrate in pre-existing circuits, is not 
well known in the enteric nervous system. One study showed that the type of neurons 
generated in response to injury express NPY, nNOS and VIP (37), a combination specific to 
enteric GABAergic interneurons (49). 
In summary, the reparative capacity of the peripheral nervous system is high; severed axons 
can regrow and neurons here are replaced both to maintain tissue homeostasis and in response 
to injury. 
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2.4.2 Regeneration in the central nervous system   
The lifelong capacity of the peripheral nervous system to repair injuries and replace neurons 
is in stark contrast to the regenerative capacity of the central nervous system, which is dismal. 
By and large, neurons lost in the brain and spinal cord will never be replaced. Instead, 
wounds such as those caused by stroke or traumatic brain injury are sealed with a scar, a scar 
that on the one hand patches up the tissue so that it retains its mechanical strength, but on the 
other hand does not at all function like normal brain tissue. Because of this, injuries to the 
central nervous system often lead to lifelong handicaps. 
The reason why the brain is so bad at repairing itself could have something to do with the fact 
that it is so incredibly complex. Its 80-90 billion neurons come in a high variety of subtypes 
and are heavily interconnected in both local and long-range circuits. Each neuron may have 
thousands of connections to other neurons. Even if a stroke or another injury damages only a 
small part, the whole brain may be affected indirectly one way or another. Therefore, 
repairing even small injuries properly would likely require large parts of the healing brain to 
re-initiate patterning programs similar to those that guided neural connectivity during brain 
development. Considering that the brain constantly needs to remain “online”, even during a 
wound healing process, such a thorough repair job may be difficult to pull off. The brain 
cannot shut parts of itself off for maintenance. 
As if this did not make brain repair difficult enough, the repair process must happen quickly. 
There are two reasons for this. First, the region surrounding a lesion suffers from extensive 
inflammation. This creates an environment that in itself will kill surviving neurons with time. 
Secondly, the damaged central nervous system becomes sensitive to mechanical stress 
because a lesion acts like a rip that disrupts the structural integrity of the tissue. In the spinal 
cord, an injury that is not patched up quickly tends to tear open from the lesion site, making 
the wound even bigger (50). Therefore, even more neurons risk dying from secondary 
damage if the healing process takes too long. 
Perhaps for these reasons, the brain does not attempt to regenerate lost tissue properly. 
Instead, it appears to prioritize minimizing the extent of secondary damage. In other words, 
better to quickly deposit scar tissue that encapsulates inflammation and re-establishes tissue 
integrity than to risk an extended healing process. A poor regenerative capacity might be the 
price our brain pays for its complexity. 
Neuronal replacement after injury does happen in some species. In salamanders, experimental 
selective ablation of dopaminergic neurons leads to replacement of these neurons (51, 52). 
Larger physical lesions, too, can heal successfully in some species. In fish, experimental stab 
wounds regenerate seemingly perfectly (53). And in the salamander, the brain will regenerate 
after the experimental removal of as much as a third of one hemisphere (230, 231, 232), and 
recreate all neuronal subtypes in their correct proportions (54). This repair capacity is 
astonishing. But even in salamanders, there are limitations to the brain’s regenerative capacity 
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after such very large lesions. Newly generated neurons fail to organize themselves properly. 
And although they successfully establish short-range neuronal connections, connections that 
extend a millimeter or more are not re-established (54). This imperfect brain regeneration in 
salamanders is a reminder of the fact that tissue regeneration is not only about recreating lost 
cell types; it is equally much about re-establishing correct tissue patterning signals that help a 
healing organ re-acquire its proper shape. Failure to do so will result in a repaired organ that 
is not identical in form to what it was before an injury. This is true for all organs, but perhaps 
demonstrated most clearly in the central nervous system. Here, organ function is intimately 
tied to organ shape because of the importance of proper neural connectivity. 
An important aspect underlying limited repair capacity in the central nervous system is that 
its neurons are very bad at regrowing their axons, in contrast to those in the periphery. This is 
partly due to an environment non-permissive to axonal regrowth. After injury, a scar forms a 
chemical barrier of inhibitory molecules (55), which effectively block axons from penetrating 
the injured region. But even in the absence of injury, the central nervous system is refractory 
to axonal growth. This is demonstrated by experimental observations of axons belonging to 
peripheral neurons that try to grow into the healthy spinal cord. Immediately upon reaching 
the boundary between the peripheral and central nervous systems, these axons promptly stop 
growing (56). One reason for poor axonal regrowth in the central nervous system is that 
axons here are not myelinated by Schwann cells capable of guiding axonal regrowth, but by 
oligodendrocytes, which do not have this guiding role. This guiding role may be crucial. In 
fact, neurons of the central nervous system can show some capacity for axonal regrowth: 
Lower motor neurons, whose cell bodies reside in the spinal cord but whose projections 
extend into the periphery, can regrow their Schwann cell-ensheathed axons if these are 
transected in the periphery (57). Yet, the ability of severed axons to form a growth cone, a 
necessary appendage, is invariably worse in in central neurons than in peripheral ones (58). 
Instead of forming a proper growth cone, neuronal subtypes that are incapable of axonal 
regrowth tend to form a retraction bulb, which contains a disorganized microtubule network. 
This tangle disables the capacity for further axonal outgrowth (59, 60). It must be mentioned 
that long-range axonal regrowth has been shown to occur in the central nervous system in 
some cases. For example, one study found that after a cortical lesion in rats, neurons from the 
intact contralateral cortex projected long-range axons (millimeters) to the de-innervated 
striatum in the injured hemisphere (61). 
Taken together, the central nervous system’s capacity for injury repair is deplorable, both 
when it comes to neuronal cell replacement and axonal regrowth. Notwithstanding these 
limitations, however, the brain is in fact incredibly plastic in other ways. This is of course 
seen clearly in the process of normal learning, which mechanistically is a remodeling of 
dendrites and synapses. This type of plasticity becomes particularly high after brain injury, 
such as a stroke. Here, neurons in intact, neighboring brain regions can rewire their local 
connections so that spared regions take over functions of lost regions, at least to some extent 
(62). This type of plasticity is responsible for the limited functional recovery seen after 
stroke. 
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Also, although most neurons are never replaced after injury, the brain is not completely 
impervious to cell replacement. Only half of all cells in the human brain are neurons (63). 
The other 50% are cells of other types: astrocytes, oligodendrocytes, oligodendrocyte 
progenitor cells, ependymal cells, microglia, pericytes and endothelial cells. Such cells do get 
replaced, even in the healthy adult brain. For example, the cell types that have been studied in 
humans – oligodendrocytes and microglia – turn over in the healthy cortex at a rate of 2.5% 
and 28% per year, respectively (6, 64). Studies in rodents have shown that in response to 
injury, also astrocytes, oligodendrocyte progenitor cells, ependymal cells, pericytes and 
endothelial cells can enter the cell cycle and at least to some extent maintain their own 
numbers (65–69). This suggests that poor neuronal replacement is not caused by the brain 
being generally hostile to cell replacement, only to that of neurons. 
 
2.4.3 Neuronal cell replacement through transplantation 
It might be possible to improve brain repair if neurons could be supplied from outside 
through transplantation. An attractive target for such a therapy is Parkinson’s disease, as this 
disease is characterized by the loss of a specific neuronal subtype (dopaminergic neurons) in 
a specific, small region of the brain (the substantia nigra). Indeed, studies in rodents have 
shown that transplanted dopaminergic neurons exert functionally beneficial effects in 
experimental models of Parkinson’s disease (70, 71). Therefore, it may in principle be 
possible to cure this disease in humans by replacing lost neurons through transplantation. 
Already in the 1980s and 1990s, clinical trials were made with this approach in patients 
afflicted with Parkinson’s disease (72). Here, neuronal precursor cells from the midbrain of 
aborted fetuses were transplanted to 300-400 patients with the hope that these cells would 
mature into functional dopaminergic neurons once they reached their target brain region. The 
results were varied. Some patients improved so much that they could be taken off of their 
normal medications. Others showed little or no effect from the treatment, and some even 
developed dyskinesias, involuntary movements, as a response to the treatment. Postmortem 
analysis of some patients, years after transplantation, showed that transplanted cells could 
indeed survive and integrate into neuronal circuits. Because of these promising but varied 
results, new and very similar trials are now being performed, this time using more stringent 
patient selection and characterization of transplanted cells (233). Cell transplantation has also 
been tried for other brain disorders, such as stroke, in early clinical trials. So far, however, 
such interventions have failed to show any robust improvement in patients (73). 
It is likely that the outcome of transplantation interventions will improve in the future. This 
will partly be due to our increased ability to characterize and produce the specific neuronal 
subtypes that are needed. Today, advances in RNA sequencing technology are enabling the 
characterization of all cell types that exist in the brain and are lost to injury. This will guide 
the derivation of specific cell types needed for successful transplantation. Furthermore, 
advances in cell reprogramming technology is improving the capacity to generate correct 
neuronal subtypes in vitro (74). For example, very exciting progress is being made on 
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generating neurons in a culture dish – cells that could in theory be used for transplantation. 
These cells have so far been generated largely from fibroblasts or astrocytes, either through 
forced expression of transcription factors (75–85), which can be aided by the addition of 
small molecules (86–88), or by only using small molecules and no gene overexpression (89–
93). 
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3 NEUROGENESIS IN THE ADULT BRAIN 
 
3.1 ADULT NEUROGENESIS – THE CONTINUED GENERATION OF NEW 
NEURONS THROUGHOUT ADULTHOOD 
Considering the difficulties with cell transplantation, it caused great excitement when it 
became clear in the 1990s that there are in fact some regions of the brain where new neurons 
are being generated throughout adulthood. In hindsight, the evidence for this had been slowly 
accumulating for decades. In the 1960s, Joseph Altman and Gopal Das published their 
finding that cells in the adult rat dentate gyrus incorporated radioactive thymidine – a sign 
that these cells were adult-born (94, 95). Maybe these cells were neurons, maybe not; the 
experimental methods were not good enough to tell. More than a decade later, Michael 
Kaplan replicated Altman’s experiment but now used electron microscopy to show that the 
adult-born cells were indeed neurons (96). Almost another decade later, Fernando Nottebohm 
demonstrated that adult-born neurons are incorporated into functional neuronal circuits, 
though this was not shown in mammals but in canary birds, whose seasonal song learning is 
accompanied by bursts of neurogenesis (97). Then, in 1992, a number of research groups 
showed that it was possible to isolate neural stem cells from the adult rodent brain and 
expand them in vitro using growth factors (98, 99). This was followed by studies confirming 
that adult neurogenesis does in fact take place in the living mammalian brain. In 1998, it was 
shown for the first time that this process also occurs in the adult human brain (100) (Figure 
4). 
 
 
Figure 4. Neurogenesis in the adult human brain. 
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This story, spanning over 30 years, may seem like excruciatingly slow scientific progress. 
But it is only with the luxury of hindsight we can see that these pieces of evidence were 
pointing to something that was real. The understanding up until this point had been that no 
neurogenesis takes place after development, and there was no clinical evidence whatsoever to 
suggest otherwise. It is often said that the discovery of adult neurogenesis broke a long-held 
“dogma” claiming that adult neurogenesis was impossible. But the prevailing view was not 
dogmatic in the sense of a doctrine laid down by an authority. Rather, the notion of adult 
neurogenesis must have appeared at the time as an extraordinary claim, which as always, 
requires extraordinary evidence. Scientists are a critical bunch and the initial findings were 
most likely met with appropriate skepticism. Unlike other important scientific discoveries – 
say, the structure of DNA – the first reports of adult neurogenesis did not immediately 
provide an explanation for some well-recognized mystery. If that had been the case, the 
scientific community might have been quicker at accepting these results. Instead, the 
discovery of adult neurogenesis preceded the questions it would provide the answer for (234). 
Therefore, the existence of this phenomenon was not broadly accepted until experimental 
methods developed to the point where the evidence for it became undeniable. Today, the 
study of adult neurogenesis has developed into an entire field of its own, with hundreds of 
articles being published each year (Figure 5). 
 
Figure 5. Number of articles about adult 
neurogenesis published per year. A diagram 
showing the number of peer-reviewed 
publications containing the search term “Adult 
neurogenesis” published per year (source: 
PubMed). Note that the drastic increase started 
at the end of the 1990s, when it became clear 
that adult neurogenesis occurs in the human 
brain. 
 
Defining which brain regions are ‘neurogenic’ and which are not may sound like it would be 
straightforward once people realized that they should look for it. But it is not that trivial to 
map the neurogenic capacity of the brain. Indeed, more than two decades on, it is still 
possible to publish a thesis on the subject. The main reason for this is the same as for the 
study of cell turnover in the rest of the body, namely that an organ may have facultative stem 
cells that do not always display their cell-producing capacity. To identify adult stem cells, 
therefore, a cell type of interest must be labeled at one time point and its behavior observed at 
a later time point. Because this is experimentally demanding, neural stem cells are most often 
studied in animal models. Laboratory animals may or may not be representative of humans. 
Yet another difficulty in the field of neurogenesis deals with the definition of ‘neurogenic’. 
Must a neurogenic region display a continuous production of neurons? Is it enough that its 
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cells have an intrinsic capacity to generate neurons even though this capacity is revealed only 
in cell culture (e.g. the rodent cortex)? Or is the main feature of a neurogenic region that it 
has an environment permissive for incorporating new neurons, even though it does not itself 
have any active neural stem cells (e.g. the rodent olfactory bulb)? 
Regardless of how a neurogenic region is defined, however, two parts of the mammalian 
brain clearly stand out – the dentate gyrus of the hippocampus and the subventricular zone 
lining the lateral ventricles. In these regions, neural stem cells generate more than a thousand 
new neurons every day in adulthood (101, 102). When this became firmly established, there 
was much hype around the possibility that adult neurogenesis might represent a previously 
undiscovered mechanism for brain repair. Perhaps the purpose of neurogenesis was to act as 
an intrinsic mechanism for brain repair that could be tweaked to work better? Yet, the more 
the phenomenon was studied, the more it became clear that newborn neurons instead play 
important roles for the normal function of the healthy brain. It turns out that young neurons 
are required for some neuronal circuits to perform certain computations. The most studied 
neurogenic region is the hippocampus, a brain structure important for learning and memory 
formation. This region can be described as a “gateway to memory”: Information that reaches 
the hippocampus, such as sensory information, is compressed, catalogued and sent on to the 
cortex where it is stored as memories. Thus, the hippocampus is not itself the place where 
memories are stored; rather, it acts like a librarian that makes sure that the right memory is 
stored in the right place and can be accessed when needed. Hippocampal neurogenesis is 
confined to a subregion called the dentate gyrus, which is placed like a bottleneck in the 
circuit through which input to the hippocampus must pass. Through neurogenesis, the dentate 
gyrus constantly maintains a pool of young neurons. Notably, newborn neurons have distinct 
electrophysiological properties for some time after they are born, which old neurons do not 
have: They are hyper-excitable and thus require weaker stimulation in order to get activated 
(103). This property appears to be important for the brain’s ability to learn new things. When 
we memorize new information (such as a text on how memory formation occurs), 
information travels through the brain in neural circuits that are not so well established. This 
makes the input to the hippocampus weak. Newborn neurons may help the hippocampus 
detect these faint signals and thus to process and store the new information as unique 
memories that are distinct from previously existing memories (104). 
In the other neurogenic region, the subventricular zone, most mammals generate immature 
neurons that migrate forward through the brain to the olfactory bulb, where they are 
integrated as mature neurons. Here, the functional role of newborn neurons is less well 
understood, but is related to certain aspects of odor discrimination (105). 
Adult neurogenesis may be described as a mechanism to replace old neurons with new ones, 
but it is worth noting that neuronal replacement should not be understood as one neuron 
dying and another coming in to take its exact place. Rather, it should be seen as a balance 
between the two parameters cell birth rate and cell death rate. Depending on how these 
parameters are tweaked, the consequences for the tissue are different. In the mouse olfactory 
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bulb, the neuronal death rate is high and neurogenesis is important for maintaining proper 
numbers of neurons. If neurogenesis is experimentally ablated, the olfactory bulb gradually 
deteriorates as neurons die off (106). In contrast, the mouse dentate gyrus has a very low 
neuronal death rate. Through neurogenesis, therefore, the total number of dentate gyrus 
neurons increases throughout life (106). In the dentate gyrus of humans, however, the 
situation appears to be slightly different. Here, even though neurogenesis happens at the same 
rate as in middle-aged mice, the neuronal birth rate appears unable to keep up with neuronal 
death rate. This means that the total number of dentate gyrus neurons declines throughout life 
(101). 
Not surprisingly, perhaps, there are differences in the extent of adult neurogenesis between 
mammalian species. In humans, a larger proportion of dentate gyrus neurons are replaced 
over a lifetime than in rodents (101). Whales and dolphins, on the other hand, barely even 
have a hippocampus and no neurons are generated there (107). Even more strikingly, 
however, is that humans, unlike other mammals, do not have any adult neurogenesis in the 
olfactory bulb (108). Perhaps this odd absence reflects the fact that the sense of smell is not as 
important in humans as it is in most other mammals. Another possibility is that the sheer size 
of the human brain would require neuroblasts to migrate such long distances to reach the 
olfactory bulb that they cannot do it (as discussed in Section 3.3.1). 
A general concept that has dominated the field proposes that, throughout evolution, the 
capacity for neuronal replacement has decreased with increasing brain complexity. This idea 
likely originates in comparisons between mammals and animal groups like amphibians, 
reptiles, and fish, in which mammals indeed have the worst regenerative capacity after injury. 
This “rule” was thought to apply even between different mammalian species. In effect, the 
common but questionable assumption that the human brain is more ‘complex’ than that of 
rodents has led to the general belief that humans likely have less neurogenesis than mice. For 
this reason, the discovery that adult humans have ongoing neurogenesis also in the striatum 
came as a surprise (109). Mice, which are the most commonly used laboratory animal, do not 
have neurogenesis in this region under normal conditions (110–113), except during a short 
period after birth (114). However, only because mice are the most commonly studied model 
organism, we must not therefore think that this species best represents the human brain. 
Humans are, for example, equally distantly related to rabbits, which do have striatal 
neurogenesis (115). In addition, some reports have claimed to detect striatal neurogenesis 
even in healthy rats and a non-human primate (116–118), though this is controversial (119, 
120). 
The functional role of new neurons in the striatum is unknown. However, adult striatal 
neurogenesis appears to be limited to the medial striatum both in rabbits, rats and squirrel 
monkeys (115, 116, 118). This brain region receives input from limbic emotional circuitry 
and the visual and auditory cortex, but not extensively from the motor cortex, which projects 
primarily to the lateral striatum (121). In the healthy striatum, turnover appears to be limited 
to a population of calretinin-expressing interneurons (109, 115, 122), though other neuronal 
 26 
subtypes may be generated after injury, at least in rats (123). In humans, 10% of striatal 
neurons belong to this interneuron subtype, but in mice, only 1% do. It is possible, therefore, 
that this subtype has a particularly prominent role in the human brain, something that might 
help explain why they turn over in humans but do not in mice. 
In addition to the brain regions mentioned here, there are occasional reports of newborn 
neurons in other healthy regions. Mostly, though, these studies are based on ambiguous 
images of single cells and have in general not stood the test of time. Of interest, however, is 
that for a short time after birth, some level of neurogenesis appears to persist in the 
hypothalamus (124), meninges (125), and cerebellum (126, 127), at least in mice. 
Though adult neurogenesis does not seem to have evolved as an intrinsic tool for brain repair, 
many studies describe that there are changes in neurogenesis in response to various injuries. 
The most well-described of these is that a great surge of neurogenesis develops in the rodent 
striatum in response to severe injury, particularly stroke. In the weeks and months following a 
stroke, large amounts of immature neuroblasts appear here. At least some of these neuroblasts 
mature and integrate as functional striatal neurons (128). However, they are few: One study 
in stroke-injured rats found that after six weeks, only 0.2% of dead striatal neurons had been 
replaced (117). In addition, the type of neurons generated in this way may not be the same as 
the types that were lost (122), though there may be species-specific differences here, even 
between mice and rats (123). In this thesis, Paper III describes work suggesting that stroke-
induced striatal neurogenesis occurs also in humans. 
Outside the striatum, injury-induced neurogenesis is extremely restricted, to the degree that it 
would not seem to be of any value for functional recovery. The cortex is a good example. 
Although some research groups have reported isolated newborn neurons in the rodent cortex 
injured by stroke or selective neuronal loss (Reviewed in (234)), other groups have not found 
any such neurons (129–132). A recent study that used radiocarbon dating to estimate the age 
of neurons in the human cortex of stroke patients found no evidence whatsoever for neuronal 
replacement (133).  
Interestingly, however, a recent study demonstrated that a population of agouti-related protein 
(AgRP)-positive hypothalamic neurons located outside the blood-brain barrier are replaced 
after selective ablation of these cells induced by monosodium glutamate injections in mice 
(134). This is fascinating, as this form of injury-induced neurogenesis is reminiscent of that 
happening in the peripheral nervous system in response to damage.  
In summary, adult neurogenesis is highly restricted to a few brain regions, both in health and 
after injury. Why should this be so? What is so special about these neurogenic regions and the 
cells located there? 
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3.2 NEURAL STEM CELLS AND THEIR IDENTITY AS SPECIALIZED 
ASTROCYTES 
The neurons that originate in the dentate gyrus and subventricular zone are made by stem 
cells (Figure 6). These neural stem cells are similar to those that exist in other organs, like the 
skin, blood and intestinal epithelium, in that they produce cells through a hierarchy of 
proliferating intermediate cells. Each time a neural stem cell divides, it generates a copy of 
itself as well as a transit-amplifying cell, the latter of which undergoes 5-6 additional 
doublings in rapid succession to generate many neuroblasts. As we have seen, such a 
hierarchical arrangement is common in organs where high cell turnover is crucial for normal 
tissue function. Since it evolved also in the neurogenic niches, it suggests that the 
mechanisms underlying neurogenesis have been under high selective pressure. It is testament 
to the importance of lifelong neurogenesis for normal brain function. 
 
 
 
 
 
Figure 6. Neural stem cell in the 
subventricular zone. 3D 
reconstruction of serial electron 
micrographs showing a neural stem 
cell (blue) in the adult mouse 
subventricular zone. Note the 
characteristic apical process, which 
contacts the cerebrospinal fluid in the 
lateral ventricle (LV), and the basal 
process, which contacts a blood vessel 
(BV, red). Also visible in the picture 
are three ependymal cells (E) and four 
neuroblasts (N). 
 
 
 
 
One question fundamental to stem cell biology is how a single population of stem cells can 
generate a diverse population of mature cells. In the subventricular zone, neuroblasts develop 
into a large variety of olfactory bulb neurons (135). Is it the case that each individual stem 
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cell is flexible enough to generate many different cell types, or are the stem cells in fact as 
diverse as the cells they give rise to? And can an individual stem cell keep dividing 
throughout life, or do stem cells take turns to proliferate? 
Traditional definitions of stem cells call for two fundamental properties: multipotency, which 
is the capacity to generate more than one cell type, and self-renewal, which is the ability to 
maintain multipotency over an indefinite number of cell divisions. If adult neural stem cells 
are isolated and cultured in vitro in the presence of growth factors, they do display these 
properties (98, 136). However, in their natural environment in the living brain, multipotency 
and self-renewal might actually only emerge on the population level. Take multipotency, for 
example. In the subventricular zone, individual stem cells produce either neurons or 
oligodendrocytes, but not both (137). Indeed, each stem cell may even be restricted to 
producing only a specific subtype of neuron (138). The situation might be similar for self-
renewal. Stem cells in the subventricular zone may spend very long periods of time in 
latency. When finally activated, they go through only one or a few quick bursts of 
proliferation, after which they fall back into an exhausted dormancy that may last for the rest 
of the animal’s life (139–141). This means that continuous, lifelong neurogenesis may in this 
region be the result of many stem cells taking turns to proliferate.  
It is possible that both multipotency and self-renewal work differently in the dentate gyrus. 
Here, some individual stem cells can generate not only neurons but also astrocytes (142). 
Whether each stem cell is also capable of sustained self-renewal is still a matter of debate. 
One study found that dentate gyrus stem cells can enter and exit an activated state more than 
once (142); another study, in contrast, found that stem cells are exhausted after only a single 
proliferative burst (143). The reason for this disagreement is not well understood. 
Regardless of the details, however, it is clear that neural stem cells can display greater 
potential in vitro than what their in vivo environment allows them to do. This reflects the by-
now well recognized fact that a stem cell’s intrinsic potential cannot be discussed without 
considering the microenvironment that surrounds it – its niche. Environmental signals reach 
stem cells in the form of growth factors and neurotrophins, neurotransmitters and receptor 
ligands of various kinds, interactions with the extracellular matrix, neurons, ependymal cells, 
immune cells, astrocytes, a highly organized vasculature, and the stem cells themselves (144, 
145). These signals feed directly into intracellular signaling circuits and prop up the stem cell 
state. 
The realization that the neural stem cell state is a product of both cell-intrinsic and -extrinsic 
factors is highly interesting. Cells with latent stem cell capacity – facultative stem cells – are 
common throughout the body but can be difficult to identify as stem cells because they 
display their stem cell properties only under certain circumstances, usually after severe injury. 
This introduces the possibility that facultative stem cells may also exist in the adult brain – 
cells whose stem cell potential is revealed only when the environment is right. What might 
the identity of such cells be? 
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Figure 7. Features shared between astrocytes and neural stem cells. Parenchymal astrocytes and 
adult neural stem cells have many properties in common. They are similar on the transcriptional level 
and express many of the same marker genes, they have similar ultrastructural and electrophysiological 
features, and they are metabolically similar (e.g. low lipid metabolism in their ground state), though 
the latter is largely inferred from RNA sequencing studies (146). They even share an intrinsic capacity 
to generate neurons, though astrocytes do not normally display this capacity. Instead, astrocytes may 
spend long periods of time in quiescence, which in fact many neural stem cells do, too. Figure 
reproduced from (9) with permission. 
 
In the dentate gyrus and subventricular zone, the neural stem cells are in fact specialized 
astrocytes (Figure 7). This is demonstrated by the fact that the transcriptomes of astrocytes 
and neural stem cells are very similar (146). For example, neural stem cells express astrocyte-
specific genes such as Cx30, GLAST (Slc1a3) and GFAP (112, 147). In addition, astrocytes 
and neural stem cells share ultrastructural features, as seen using electron microscopy (148, 
149), and electrophysiological properties (150).  
The fact that neural stem cells are specialized astrocytes warrants a closer look at the 
properties of the astrocytes that occupy the rest of the brain, outside the neurogenic niches. In 
the human brain, about half of all cells are neurons and the rest is a mix of glial cells and 
other cell types. Astrocytes are distributed throughout the central nervous system. In the 
mouse, they make up 10-20% of all brain cells (151). They are, however, not evenly 
distributed throughout the brain. In the mouse cortex, hippocampus and spinal cord, 12-17% 
of all cells are astrocytes, whereas the corresponding number in the cerebellum and olfactory 
bulb is only 3-4% (151). Astrocytes are crucial for regulating many homeostatic functions in 
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the brain, including synaptic transmission, ion transport and regulation of pH and the blood-
brain barrier. In addition, they mount an important response to injury known as reactive 
gliosis. 
The similarity between astrocytes and neural stem cells is not limited to gene expression and 
morphological properties. In fact, it also encompasses an intrinsic capacity to generate 
neurons. If astrocytes are isolated from the injured brain parenchyma and cultured in vitro in 
the presence of growth factors, they activate stem cell-like properties and generate neurons in 
the culture dish (152–154). Now, we and others have found that some astrocytes can even 
generate neurons in vivo after certain injuries (112, 113). These findings are described in this 
thesis. 
 
3.3 STIMULATING ENDOGENOUS NEUROGENESIS  
The realization that some brain regions continuously generate neurons suggested that 
neurogenesis might be recruited for therapeutic purposes, to replace neurons lost to injury or 
disease throughout the brain. For this, two general strategies have been and are being 
pursued, both of which have strengths and weaknesses. 
 
3.3.1 Stimulating neuroblast migration from the subventricular zone 
The most straightforward strategy may be to recruit the stem cells in the brain’s neurogenic 
regions, boost their output and direct the migrating neuroblasts to an injured brain region. 
Normally, the rodent subventricular zone may only be able to generate neurons for the 
olfactory bulb; however, in response to stroke there is increased proliferation and 
neurogenesis, followed by neuroblast migration into the injured striatum (117, 155, 156). 
This shows that neuroblasts do have the ability to migrate through the brain parenchyma 
toward a lesion, thus making the strategy feasible in theory.  
Neural stem cell proliferation in the subventricular zone can be boosted artificially, even in 
the absence of severe injury, by injecting growth factors such as EGF, FGF2 or TGF-α 
directly into the lateral ventricles or the striatum of rodents. However, this on its own does 
not lead to neuroblast migration into the striatum unless it is performed together with an 
experimental injury, such as stroke or a 6-OHDA lesion, or in an R6/2 mouse model of 
Huntington’s disease (110, 157, 158). This is because the critical guidance cue needed to 
direct neuroblasts into the brain parenchyma appears to be the inflammation caused by injury. 
Striatal injection of lipopolysaccharide (LPS), a bacterium-derived molecule that causes 
strong inflammation without causing great injury, is as effective as stroke at promoting 
migration of neuroblasts into the striatum (159). This neuroblast attraction is mediated at least 
in part by the inflammatory cytokines CXCL12 (SDF1) (160–162), CXCL13 (159), and 
CCL2 (MCP1) (163), as well as Osteopontin (164) and Angiopoietin (165), at least in 
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rodents. It is not known whether it would be possible to stimulate neuroblast migration in 
humans in the same way. 
This approach may sound straightforward, but it has a number of problems. First of all, neural 
stem cells may be restricted to generating only particular types of neurons. Even after a stroke 
has affected the striatum, new-made striatal neurons are mostly interneurons, which constitute 
a minority of all striatal neurons. It is not known whether subventricular zone stem cells have 
the capacity to generate the full complement of neuronal subtypes that need to be replaced 
after an injury.  
Secondly, from the perspective of a migrating cell, the distances in the brain are very large, 
and brain tissue is tightly packed with cells and extracellular matrix. In order to squeeze 
themselves forward through this dense medium, neuroblasts first project filaments that 
dynamically probe their surroundings. Then, the entire cell drags itself forward within one of 
these filaments – a bit like how an earthworm crawls (156, 166). To help in this process, they 
secrete matrix metalloproteinases that break down extracellular matrix in their path (167). 
Neuroblasts prefer to migrate along blood vessels, perhaps because this is faster. Even so, 
they are relatively slow, migrating through brain tissue at a speed of only about 12 µm per 
hour (168). This means that even if the subventricular zone would in principle be capable of 
producing neurons for the whole brain, the sheer distances that neuroblasts would need to 
traverse are huge. For example, a stroke injury located only 5 cm away from the 
subventricular zone would take 170 days for a neuroblast to reach, even if it migrated in a 
perfectly straight line, which it most likely would not do. By that time, the stroke lesion 
would have already reached the chronic phase and it is not certain whether it would still be 
secreting the factors needed to attract neuroblasts, or indeed whether there would still be any 
use for new neurons in circuits that had already had half a year to adapt in other ways. For 
this reason, the subventricular zone could probably only be a useful source for new neurons if 
injuries are very near. For all other brain regions, any endogenously produced neurons must 
likely come from more local sources*. 
 
3.3.2 Reprogramming of glial cells 
Another idea for how to generate new neurons within the brain is to recruit local non-neurons 
as a source for these cells. This idea derives primarily from two separate lines of evidence. 
The first is that glial cells can be isolated from non-neurogenic regions of the brain, and 
pushed to generate neurons in vitro when stimulated with the right growth factors (152–154). 
This means that the brain is in fact full of cells with an intrinsic potential to generate neurons, 
though these cells never realize this potential in the living brain. In rodents, these cells are 
                                                
* Similarly, as mentioned in Section 3.1, brain size could also be the reason we humans have lost 
olfactory bulb neurogenesis, as this would require neuroblasts to migrate very far from the 
subventricular zone. 
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astrocytes (153) and ependymal cells (169) but not oligodendrocyte progenitor cells (NG2 
cells) (170). 
The other line of evidence is the discovery that virtually any differentiated cell in the body 
can be reprogrammed to a pluripotent stem cell, which in turn can be made to differentiate 
into any cell type of interest (171, 172). This discovery was awarded with the Nobel Prize in 
2012. In principle, this means that every cell in our body is a potential stem cell with the 
highest developmental potential. In reality, though, cells do not undergo such transformations 
in the body because their identities are firmly locked into place by epigenetic mechanisms 
and transcriptional networks (173, 174). Instead, to reprogram cells like this requires the 
artificial expression of key genes. This is in principle possible in the brain. However, the fate 
of pluripotent stem cells cannot easily be controlled. Therefore, it would be more desirable to 
generate neurons through a more direct route. This, too, is possible. In fact, it can be easier to 
reprogram one differentiated cell type directly into another cell type, especially if the two are 
closely related. This is because similar cells have similar transcriptomes (175), and smaller 
perturbations may therefore be needed to convert one into the other. 
Together, these two lines of evidence show that there are cells in the brain that are very 
closely related to neural stem cells, and that relatively small genetic manipulations may be 
sufficient to turn them into neural stem cells, or even directly into neurons. Current research 
suggests that this is a realistic goal to pursue, and great advances have been made to this end 
during the past decade. This in vivo reprogramming could in principle be achieved in two 
ways – either through the direct conversion of each starter cell into one neuron, or by first 
converting each starter cell into a neural stem cell-like cell that in turn generates neurons. The 
second of these is the main topic of this thesis and will be discussed in the Results and 
Discussion section. 
 
3.3.3 Transdifferentiation – the direct conversion of starter cell to neuron 
Many studies now show that it is possible to force cells to turn from one cell type into another 
by overexpressing select transcription factors in them (176–178, 83, 179). In the brain, this 
has been successful using astrocytes or NG2 cells as starter cells. The transcription factors 
used are selected for their important roles in instructing neuronal identity during normal brain 
development. When these genes are artificially overexpressed in adult cells, they work by 
superimposing a neuronal transcription factor network onto that of the starting cell, leading to 
direct transdifferentiation within a few days. For example, the proneural transcription factor 
Ascl1 is often included for its important ability to make chromatin more accessible and allow 
other transcription factors to bind DNA (180). Such other transcription factors often specify a 
broad neuronal identity and include Brn2, Myt1l, Zfp238, Sox2, Neurog2, Neurod1, Pax6 
and Dlx2 (178, 83, 181, 182, 81, 183). Interestingly, although reprogramming has most often 
been induced by forced overexpression of transcription factors, a number of studies now 
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show that in vitro reprogramming is also possible by using pharmaceutical compounds alone 
(90, 89, 184). 
In one study, single-cell RNA sequencing was used to study the transcriptional changes that 
occur as fibroblasts are converted to neurons using Brn2, Ascl1 and Myt1l in vitro (185). As 
transdifferentiation was initiated, the authors found, the starting cell’s transcriptional profile 
was gradually lost, and at the same time, that of the target cell was gradually acquired. 
Interestingly, genes associated with neural stem cells were transiently expressed halfway 
through the process. Even so, direct transdifferentiation does not proceed along the same 
steps as normal neuronal differentiation does (174, 186). Importantly, cells do not pass 
through a bona fide stem cell state, which includes proliferation to generate transit-amplifying 
cells. Indeed, direct transdifferentiation does not require cell division at all (187). This means 
that for every neuron that is generated, one starter cell is consumed. It is possible that 
neuronal transdifferentiation on a massive, therapeutic scale may thus significantly impact the 
ratio of neurons to glia in the brain, which is roughly 4:1 in the cortex, 1:4 in the cerebellum, 
and 11:1 in the basal ganglia, diencephalon and brainstem (63). Whether this would have any 
functional consequences is not known, but the ratio of glia to neurons is probably important 
for proper function of neural circuits: Disturbances in this ratio are seen in many 
neurodevelopmental disorders (188). It is, however, equally possible that remaining glial cells 
would step in and replenish their own numbers through cell division. In mice, this has been 
conceptually demonstrated for NG2 cells, which proliferate to re-establish correct numbers if 
some of them are lost (66). Astrocytes, too, can divide to generate more astrocytes after brain 
injury (65).  
The fact that there is no expansion in cell numbers during the process of direct 
transdifferentiation suggests that this method may not be suitable for generating a large 
number of neurons. This prompts the question of how many new neurons are actually needed 
for there to be a significant improvement in brain function. The transplantation studies 
mentioned above showed that behavioral improvements could be detected after 
transplantation of only a few thousand neurons (71). Importantly, such positive effects have 
also been seen when neurons were generated through transdifferentiation of endogenous 
cells. In one study, the generation of a few hundred dopaminergic neurons, at most, led to a 
small but statistically significant behavioral improvement in a mouse model of Parkinson’s 
disease (189) 
These advances are promising. Nonetheless, an attractive alternative to direct reprogramming 
might be to make each starter cell generate many neurons instead of just one. As we have 
seen, the tissues and organs with the highest demand for cell replacement tend to employ 
stem cells, a setup that allows each starter cell to generate a large number of progeny via 
highly proliferative transit-amplifying cells. This is also the mode by which neural stem cells 
generate neurons in the subventricular zone and dentate gyrus. Considering the close 
relationship between neural stem cells and astrocytes, an exciting possibility is therefore 
whether astrocytes can be converted into neural stem cells.  
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4 CONCLUDING REMARKS 
 
Having surveyed the reparative capacity of many tissues and organs, we can now take a more 
holistic view and place the regenerative capacity of the central nervous system in a bigger 
context. It is clear that injury repair in the brain and spinal cord suffers from the same 
limitations as those seen in other organs: a tendency for scar formation, imperfect cell 
replacement, and a poor capacity for tissue patterning. However, in the central nervous 
system, these limitations have some very special consequences. For example, a scar in the 
brain does not substitute for any normal brain function, the way it does in structural tissues 
like the skin. Cell loss, too, has particularly devastating consequences in the brain. This is 
because each brain region is more or less uniquely responsible for a particular body function. 
Therefore, even small lesions may lead to complete loss of certain brain functions. In 
contrast, the function of many other organs is distributed evenly across the entire organ. In 
organs like the lungs and the intestine, damage tends to cause a gradual worsening of overall 
tissue function. Finally, the central nervous system’s function is almost entirely determined 
by the complex circuitry of its neurons. This places great demand on the capacity of the brain 
to establish an appropriate tissue patterning environment after injury. If the healing brain fails 
to provide the patterning signals required for axons to reach their appropriate targets, tissue 
function will not be properly restored. This is in contrast to an organ like the liver, which 
does not require perfect tissue patterning to become functionally equivalent to what it was 
before an injury.  
The brain does generate new neurons in certain regions throughout adulthood, and it does so 
through the use of specialized stem cells. Conspicuously enough, in other parts of the body 
adult stem cells are a hallmark feature of organs that require very rapid cell turnover for 
normal tissue function. Clearly then, the fact that the neurogenic regions are so obviously 
optimized for high neuronal output must say something about the evolutionary pressures that 
have shaped adult neurogenesis in our ancestors, and possibly also about the importance of 
this phenomenon in the modern human brain. Yet, this sleek neurogenic machinery has 
evolved right in the middle of an organ that is otherwise almost totally devoid of neuronal 
replacement – a seemingly paradoxical contrast. 
Throughout the body, organs with low to medium levels of cell turnover often rely on the 
duplication of pre-existing differentiated cells for tissue homeostasis; examples include such 
diverse cell types as hepatocytes, microglia and most epithelial cells (3, 4, 6, 7). This 
mechanism would seem to be appropriate also for the replacement of neurons in the brain 
parenchyma, as these normally require very little cell replacement. However, mature neurons 
do not replicate themselves. In fact, if artificially stimulated to divide, neurons would rather 
undergo apoptosis than enter the cell cycle (190). Thus, the fact that the brain is unable to use 
this simple mechanism to replicate its neurons could be an underlying factor for its poor 
reparative capacity. 
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Outside the brain, one additional mechanism exists for replacing cells when the normal 
modes of cell replacement are not enough: facultative stem cells. As described previously, 
severe injuries can lead to the recruitment of stem cells which do not normally act as stem 
cells. In some organs, these cells appear to do little else than wait to be called into action – for 
example, satellite cells in skeletal muscle or +4 cells in intestinal crypts. In other cases, they 
serve specialized roles unrelated to their latent stem cell capacity – for example, club cells in 
the lungs, or tubular epithelial cells in the kidneys. Turning to the brain, the question has 
remained whether any facultative stem cells exist whose neurogenic capacity has not yet been 
discovered. In the peripheral nervous system, the astrocyte-like satellite glial cells fulfill this 
role, as discussed previously. The fact that astrocytes are conspicuously similar to neural stem 
cells, and the observation that they can display neurogenic properties if isolated and cultured 
in vitro, has suggested that a closer study of this cell type’s neurogenic capacity in vivo may 
be warranted. 
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5 METHODS 
 
5.1 CELL FATE MAPPING 
Adult stem cells can often not be recognized in histological tissue sections because stem cells 
do not have a characteristic morphology that sets them apart from non-stem cells. Instead, 
identification of stem cells relies on the experimental labeling of cells at one time point and, 
at a later time point, analysis of the labeled cells to see what they have done. One way of 
doing this is to treat animals with a compound called bromodeoxyuridine (BrdU), a DNA 
nucleotide analog containing a bromine atom in place of a CH3 group. When any cell in the 
body divides, it synthesizes new DNA and will randomly incorporate the blood-borne BrdU 
into its genome. Later, tissue sections can be analyzed using fluorescently labeled antibodies 
against BrdU, and in this way it is possible to see what cells had become that divided at the 
time of BrdU administration. This technique and variations of it are tremendously useful in 
stem cell biology. For example, the first generation of nucleotide analogs were based on 
radioactive thymidine. It was these that enabled the first evidence of adult-born neurons in the 
rat dentate gyrus (95, 96).  
However, BrdU is incorporated into any cell that divides. Therefore, if a BrdU+ cell is spotted 
in the tissue, it is not possible to deduce its origin - whether it was generated through the mere 
duplication of an identical cell or whether a stem cell gave rise to it. For this reason, a 
different technique has become even more useful - genetic fate mapping (also called lineage 
tracing). This technique relies on the use of genetically modified animals, often mice, that 
carry a specific genetic construct. Here, the DNA-cutting enzyme Cre is expressed under the 
control of a cell type-specific promoter. In Papers I and II, Cre was expressed under the 
control of the astrocyte-specific Connexin-30 promoter, and thus, Cre is expressed only in 
astrocytes. In a further twist, Cre is fused to the estrogen receptor (ER), which means that the 
CreER fusion protein cannot enter the nucleus unless estrogen or an analog like tamoxifen is 
present. Once mice are treated with tamoxifen, CreER enters the cell nucleus and makes a cut 
in another transgene, the result of which is the heritable expression of a fluorescent reporter 
gene such as yellow fluorescent protein (YFP) or tdTomato. In effect, tamoxifen 
administration makes astrocytes fluorescent, and any cell type the astrocytes might give rise 
to will also be fluorescent. This technique is enabling the identification of stem and 
progenitor cells throughout the body of experimental animals. It does, however, require the 
use of transgenic animals, the generation and maintenance of which is very time consuming. 
Each such mouse strain enables the tracing of only one or a few cell types, making a detailed 
mapping of the developmental potential of every cell type in the body very work-intensive. In 
addition, because not all cell types have unique marker genes that set them apart from other 
neighboring cells, transgenic mice do not exist for every cell type in the body. 
  
  37 
5.2 RADIOCARBON DATING TO ESTIMATE CELL TURNOVER 
One significant limitation with BrdU and genetic fate mapping is that they are not routinely 
applicable to humans for ethical reasons. Therefore, a technique has been developed in the 
Frisén lab that uses 14C dating to birth date human cells in postmortem samples. The 
atmospheric levels of 14C have been stable for a long time but rose drastically as a result of 
above-ground nuclear bomb tests between the 1950s and early 1960s (191, 192). Following 
the partial nuclear test ban treaty in 1963, the atmospheric 14C levels started decreasing 
exponentially, not due to radioactive decay (14C has a half-life of 5730 years) but due to 
equilibration with the oceans and the biosphere (193). Plants take up atmospheric 14C through 
photosynthesis, and humans take up 14C by eating plants or animals that live off plants. 
Therefore, the 14C concentration in our body reflects that in the atmosphere at any time (194, 
195). When a cell in our body divides, it synthesizes new DNA, which consists of 30% 
carbon. Its genomic 14C concentration therefore corresponds to that in the atmosphere at the 
time the cell divided. Because DNA is a very stable molecule, every cell in effect has its birth 
date stamped into its DNA, written in 14C. By isolating the DNA from a population of cells 
and measuring the 14C concentration using accelerator mass spectroscopy, the average age of 
that cell population can be measured. This method has been used extensively by the Frisén 
lab to assess the turnover dynamics of various cell populations in the adult body (6, 101, 196, 
197). In Paper III, we applied this technique to address whether stroke leads to increased 
neurogenesis in the striatum of humans. 
This method is powerful because it enables the retrospective birth dating of cells in humans 
without requiring pre-treatment of any tracer molecule like BrdU. We are all, in principle, 
labeling ourselves all the time through the food we eat. However, experimental protocols are 
very time-consuming and work-intensive, as each investigated cell type requires material 
from many subjects, which can take months or years to collect. In addition, the method 
requires cell nuclei to be isolated by labeling them with fluorescent antibodies against unique 
nuclear markers. Such markers do not exist for all cell types. Furthermore, the limited 
sensitivity of accelerator mass spectrometry requires millions of nuclei to be extracted from 
each subject, which may not always be possible if the cell population of interest is small. 
 
5.3 SINGLE-CELL RNA SEQUENCING 
A cell’s identity and behavior is governed by the genes it expresses. Sequencing a cell’s 
transcriptome thus gives a snapshot picture of the cell’s current state. The recent development 
of “next-generation” sequencing has enabled the rapid emergence of single-cell sequencing 
as a field that is now evolving at a high pace (198). By analyzing cells on the single-cell level, 
cell heterogeneity can be dissected in ways that are not possible when studying cells in bulk. 
For example, a collection of actively proliferating stem cells and their progeny will contain 
cells in all stages of maturation. Only through single-cell analyses can this heterogeneity be 
resolved. Therefore, single-cell RNA sequencing is now being used to generate an extensive 
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catalog of the cell types and developmental stages that exist in the body. In Paper II, single-
cell RNA sequencing was used to analyze astrocytes undergoing neurogenesis in vivo, with 
two aims in mind. The first aim was to computationally reconstruct the differentiation 
trajectory of striatal neurogenic astrocytes, to understand this biological process in more 
detail. The second aim was to compare gene expression between astrocytes that underwent 
neurogenesis with those that did not. Differentially expressed genes highlighted a number of 
signaling pathways whose activity level might confer neurogenic ability on astrocytes. We 
used this information to guide further in-vivo interventions whose aim was to stimulate 
neurogenic lineage progression in non-neurogenic astrocytes. Applying single-cell RNA 
sequencing analysis in this way has not been extensively used before. 
Today, a handful of techniques exist for preparing RNA libraries for sequencing. In Paper II, 
we used SmartSeq2, a protocol whose strength is that it enables the detection of full-length 
transcripts, but has the drawback that absolute transcript counts based on unique molecular 
identifiers (UMIs) cannot be used (199). Computational tools abound for computationally 
classifying cell types in a heterogeneous population or cells along different stages of a 
differentiation process. These tools are available and are relatively easy to apply in 
programming languages like R thanks to the existence of many pre-made packages. 
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6 PRESENT INVESTIGATION 
 
6.1 AIMS 
Paper I – To investigate whether astrocytes in the adult mouse brain can generate neurons in 
response to stroke, and if so, what the molecular mechanisms are that govern this process 
Paper II – Aim 1: To use single-cell RNA sequencing to investigate the transcriptional 
mechanisms underlying astrocyte neurogenesis. Aim 2: To compare gene expression between 
neurogenic and non-neurogenic astrocytes, using this information to guide interventions that 
may stimulate astrocytes to undergo neurogenesis in otherwise non-neurogenic regions. 
Paper III – To investigate whether stroke-induced neurogenesis occurs in the human 
striatum 
Paper IV – To develop spatial transcriptomics, a method for performing RNA sequencing 
on intact tissue sections with retained spatial information 
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6.2 PAPER I 
6.2.1 Summary of results 
The similarity between neural stem cells and astrocytes (Section 3.2) prompted the question 
of whether astrocytes can generate neurons in vivo under some circumstances. This question 
was addressed in Paper I.  
Using transgenic reporter mice expressing CreER under the control of an astrocyte-specific 
Connexin-30 (Cx30) promoter, we could label astrocytes with heritable YFP expression in 
the healthy brain and follow their fate after stroke. Indeed, from two weeks after stroke and 
onwards, we observed YFP+ transit-amplifying cells and neuroblasts in the striatum. Many of 
these cells were found in proliferating clusters, suggesting that they were being produced on 
site. At a later time point, seven weeks after stroke, we even observed that some of these cells 
had developed into mature interneurons. This showed that the Cx30-CreER+ cells that were 
labeled before the stroke could generate neurons. 
However, the Cx30-CreER mice labeled not only astrocytes, but also neural stem cells in the 
subventricular zone. Subventricular zone-derived neuroblasts can migrate into the stroke-
injured striatum (155, 156). We could therefore not exclude that the YFP+ neuroblasts and 
neurons we observed in the striatum had migrated from the subventricular zone. For this 
reason, we used a different method to follow the fate only of striatal astrocytes. We injected 
an astrocyte-specific adenovirus, carrying the Cre gene, into the striatum. This allowed us to 
activate YFP expression only in striatal astrocytes and not in subventricular zone cells. When 
these mice were analyzed after stroke, we found that some striatal transit-amplifying cells and 
neuroblasts were YFP+, meaning that they had indeed been generated by the striatal 
astrocytes that were labeled prior to stroke. 
We asked what the molecular mechanism is that regulates stroke-induced astrocyte 
neurogenesis. The Notch signaling pathway is a known regulator of neurogenesis by neural 
stem cells. For example, if the Notch-mediating transcription factor Rbpj is deleted in 
subventricular zone stem cells, they all undergo premature neurogenesis and are themselves 
consumed by this process (200). We asked whether astrocyte neurogenesis, too, is regulated 
by Notch. For this, we used a variant of the Cx30-CreER mouse that carried an inducible 
form of the activated Notch1 receptor (NICD). In effect, astrocytes in these mice had 
constantly active Notch signaling. We reasoned that if Notch downregulation is the 
mechanism by which stroke normally triggers astrocyte neurogenesis, astrocytes in this 
mouse should be unable to undergo neurogenesis. That was indeed what we found. After 
stroke, none of the NICD-expressing astrocytes had generated transit-amplifying cells or 
neuroblasts. This showed that Notch downregulation normally is necessary for astrocyte 
neurogenesis after stroke. 
If astrocytes require Notch downregulation to initiate their neurogenic program, we finally 
asked whether astrocyte neurogenesis could be activated even in the absence of stroke by 
artificially inactivating the Notch pathway. For this, we used transgenic Cx30-CreER mice 
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carrying inducible null mutations in Rbpj, the crucial Notch-mediating gene. When Rbpj was 
deleted in astrocytes throughout the brain of healthy mice, we found that they generated 
transit-amplifying cells, neuroblasts and neurons, both in the striatum and in a narrow region 
of the midline cortex, even in the absence of stroke. To exclude that these cells had been 
generated by migrating subventricular zone cells, we repeated the experiment but this time 
deleted Rbpj exclusively in striatal astrocytes using the Cre-expressing adenovirus. Indeed, 
this experiment confirmed the previous one: Inactivation of the Notch pathway in striatal 
astrocytes is sufficient to trigger entry into a neurogenic program, whereby astrocytes initiate 
transit-amplifying divisions and generate neuroblasts, some of which mature into 
interneurons. 
 
6.2.2 Discussion (Paper I) 
These results are highly interesting because they demonstrate for the first time that astrocytes 
can generate neurons in the living brain (Figure 8). In effect, these results serve to blur the 
already diffuse boundary between astrocytes and neural stem cells (see Figure 7). Shortly 
after these results were published, another research group published a similar finding, that 
astrocytes in the adult mouse striatum can generate neuroblasts in response to an excitotoxic 
lesion (113). Together, these results indicate that some astrocytes in the mouse brain show the 
classic hallmarks of facultative stem cells (Section 2.3), namely an extended state of 
quiescence followed by injury-induced activation of stem cell properties. 
 
 
Figure 8. Astrocytes in the striatum undergo neurogenesis in response to stroke or Rbpj deletion. 
Paper I shows that astrocytes in the adult mouse striatum activate a neurogenic program in response to 
experimental stroke or Rbpj deletion. They generate transit-amplifying cells that divide four to five 
times, generating ~40 neuroblasts per starting astrocyte. Some of these neuroblasts mature into 
neurons. 
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Interestingly, activation of astrocyte neurogenesis in the healthy mouse striatum by genetic 
manipulation was shown in yet another study (201). Here, the overexpression of Sox2 made 
astrocytes initiate rounds of transit-amplifying divisions and generate neuroblasts, in a 
process that looked identical to what we observed after Rbpj deletion. It is interesting to 
speculate that many possible ways may exist to provoke the molecular programs that govern 
astrocyte neurogenesis. Mechanistically, this might be explained by the stabilization or 
destabilization of cross-repressing transcriptional programs responsible for governing 
competing cell identities (9). 
The results presented in Paper I introduce the tantalizing possibility that it might be possible 
to recruit astrocytes throughout the brain as an abundant source of new neurons. However, 
following the observations presented here, two questions presented themselves: Why could 
astrocyte neurogenesis only be provoked in the striatum and midline cortex, and not in other 
regions of the central nervous system? And do humans, too, have stroke-induced 
neurogenesis in the striatum? 
 
6.3 PAPER II 
6.3.1 Summary of results 
In Paper I, we had found that Rbpj deletion activates neurogenesis by astrocytes in the 
striatum and midline cortex. However, in no other regions did astrocytes undergo 
neurogenesis, despite having lost the Rbpj gene. Single-cell RNA sequencing is a powerful 
method for understanding cells on a transcriptional level and it enables the reconstruction of 
cell differentiation trajectories using computational tools. We asked whether we could use 
single-cell RNA sequencing to characterize the transcriptional programs underlying astrocyte 
neurogenesis in the striatum, and understand why astrocytes in other regions are unable to 
undergo neurogenesis. 
Our single-cell RNA sequencing analyses showed that astrocyte neurogenesis happens 
through the same general steps as that by adult neural stem cells. In particular, genes 
associated with gene expression and cellular metabolism are upregulated early as the 
neurogenic program is activated. Astrocytes then undergo rounds of transit-amplifying 
divisions to generate neuroblasts. A direct comparison with a previously published dataset of 
subventricular zone stem cells and their progeny (146) revealed that astrocytes are located 
“upstream” of neural stem cells on one single differentiation trajectory, as if representing a 
highly quiescent form of neural stem cells (Figure 9). 
Our experiments from Paper I had shown that even though striatal astrocytes can undergo 
neurogenesis after Rbpj deletion, not all of them do so. Our RNA sequencing data 
corroborated these findings, suggesting that many striatal astrocytes halted their neuronal 
lineage progression immediately prior to cell cycle entry. By stimulating cell division of 
striatal Rbpj-deficient astrocytes using the growth factor EGF or experimental stroke, we 
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could greatly increase the amount of astrocytes that entered transit-amplifying divisions, 
demonstrating the importance of mitogenic stimuli for proper neurogenic lineage progression.  
Next, we asked why astrocytes outside the striatum and midline cortex could not complete 
neurogenesis after Rbpj deletion. Our RNA sequencing data showed that even in the non-
neurogenic somatosensory cortex, Rbpj-deficient astrocytes did in fact initiate neurogenesis 
but that they, too, halted their lineage progression immediately prior to cell cycle entry. We 
found that pre-division astrocytes in the somatosensory cortex differed from those in the 
striatum mainly with regard to genes involved in proliferation-regulating pathways, like 
MAPK/ERK, PI3K/AKT and Wnt. These results suggested that strong enough mitogenic 
stimuli might be able to push Rbpj-deficient astrocytes into transit-amplifying divisions and 
neurogenesis in the somatosensory cortex and, perhaps, other parts of the central nervous 
system. Identifying such mitogenic stimuli will be an important goal for future studies. 
 
 
Figure 9. Astrocytes are located upstream of neural stem cells on a one-dimensional 
differentiation trajectory. Results from Paper II indicate that astrocytes represent a highly quiescent 
form of neural stem cells, illustrated in this schematic representation of a one-dimensional 
differentiation path. After stroke or Rbpj deletion, they fall in line with the same neurogenic trajectory 
as that of adult neural stem cells. Image credit: Mattias Karlén 
 
6.3.2 Discussion (Paper II) 
The findings presented in this study are interesting for a number of reasons. First, they show 
that the neurogenic programs of astrocytes and neural stem cells are very similar on the 
transcriptional level. This indicates that it may be meaningful to think of astrocytes as highly 
quiescent neural stem cells. Secondly, these results show that Notch inactivation is sufficient 
to initiate the neurogenic program in astrocytes even outside the striatum and midline cortex. 
Nonetheless, an additional push by mitogenic signals might be needed to force these primed 
astrocytes into transit-amplifying divisions. In other words, the Notch downregulation that 
occurs naturally as a reaction to a nearby stroke may serve to place astrocytes in a “primed” 
state, in which subsequent mitogenic stimuli activate actual neurogenesis. Such injury-
induced priming has been described also for the stem cells of skeletal muscle – the satellite 
cells. These cells enter a primed state as a reaction to a distant injury, in which they are 
poised for cell cycle entry (202). This type of priming is useful because the first cell division 
after quiescent stem cell activation takes a long time to complete (203). Thus, initial priming 
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followed by a requirement for mitogens might represent a general principle of facultative 
stem cell activation. Interestingly, even the molecular mechanisms may be similar between 
astrocytes and as satellite cells, as the latter cell type’s re-entry into quiescence depends on a 
reactivation of Notch signaling (204). 
An additional mechanistic insight into the molecular program underlying astrocyte 
neurogenesis concerns the role of reactive gliosis. Previous studies have shown that 
astrocytes can be isolated from the injured mouse brain and generate neurons in vitro, as 
discussed in Section 3.2 (152–154). The requirement for a preceding injury in some studies 
has led to the conclusion that reactive gliosis (Section 3.2) is a prerequisite for the in-vitro 
neurogenic properties of astrocytes. The results from both Paper I and Paper II show, 
however, that astrocyte neurogenesis does not fundamentally require reactive gliosis. After 
Rbpj deletion in healthy mice, astrocytes in the striatum and midline cortex underwent 
neurogenesis without any signs of reactive gliosis (Paper I). Even after stroke, Ascl1-
expressing astrocytes existed that did not show signs of reactive gliosis. Conversely, only a 
minority of reactive astrocytes expressed Ascl1. This demonstrates that the transcriptional 
programs that govern astrocyte neurogenesis and reactive gliosis are not necessarily coupled, 
though they are mutually compatible. However, reactive gliosis may be important because it 
primes cells for division. In Paper II, our results clearly highlight the importance of mitogenic 
stimuli for neurogenic astrocytes to enter transit-amplifying divisions. Because severe brain 
injury leads to astrocyte proliferation (65), these results suggest that the mechanism by which 
reactive gliosis facilitates astrocyte neurogenesis is by making astrocytes more prone to enter 
the cell cycle. 
One main insight from Paper II is that astrocytes from the non-neurogenic somatosensory 
cortex, and perhaps throughout the central nervous system, have an intrinsic capacity to 
generate neurons but that not all of them display this capacity in vivo. Our analysis 
highlighted the importance of regional differences in the extracellular environment for 
influencing astrocyte neurogenesis. However, it should not be ruled out that cell-intrinsic 
differences between astrocytes exist as well. Astrocytes are variable in both form and 
function. For example, one of the clearest differences in astrocyte morphology can be seen 
between those in the gray and white matter. Even so, apart from such morphological variety, 
the extent and origin of astrocyte heterogeneity is not well known. But emerging evidence is 
suggesting that astrocytes may actually be surprisingly homogeneous on the transcriptome 
level, at least compared to neurons. Such evidence comes primarily from RNA sequencing 
studies. In one study, where cells from the mouse cortex and hippocampus were analyzed 
using single-cell RNA sequencing, only 2 astrocyte subtypes were detected, compared to 29 
subtypes of neurons (205). A similar study found that astrocytes in the mouse striatum did not 
fall into clear subgroups at all, but were distributed along a diffuse continuum of subtle 
transcriptional differences (206).  
How such differences come about is not well known. One possibility is that they were 
imbued into astrocyte progenitors already during early nervous system development. In the 
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developing neural tube, dorsoventral patterning generates what will later become distinct 
radial glial domains in the ventricular zone (207). Later during development, the radial glia-
derived astrocytes migrate radially outwards from the ventricular zone to take up regionally 
distinct positions in the brain, where they remain for life (208). Because the distribution of 
adult astrocytes reflects the radial glial domains in the early neural tube, it is theoretically 
possible that some regional properties were inherited from the earliest tissue patterning 
events. However, the extent to which this is actually true is not known.  
An alternative hypothesis, for which there is evidence, posits that regional differences 
between astrocytes instead arise as adaptations to local environmental signals. One study 
showed that some properties of astrocytes in the cerebellar cortex are influenced by signals 
from surrounding neurons – in particular secreted Sonic hedgehog (209). This suggests that 
many other astrocyte properties, too, may be dictated by environmental signals. For example, 
the intrinsic neurogenic property observed in some astrocytes could in principle be subject to 
such environmental regulation. Whether this is actually the case is not known, but this 
question is the main topic of this thesis. 
Taken together, current evidence suggests that astrocytes are much less diverse than neurons 
and that the differences between them are subtle and arise as local adaptations to the needs of 
surrounding neurons. Yet, it should not be ruled out that some form of astrocyte 
heterogeneity remains from differences in astrocyte progenitors during brain development – 
perhaps also differences in neurogenic capacity. 
 
6.4 PAPER III 
6.4.1 Summary of results 
A well established fact is that stroke-induced neurogenesis takes place in the striatum of 
rodents (123). Many of the neuroblasts that appear in the striatum have migrated from the 
nearby subventricular zone (155, 156); others have been generated by local striatal astrocytes, 
as we show in Paper I. Whether anything similar happens in the human stroke-injured brain is 
not known, but the answer is important: Stroke often leads to lifelong handicaps, but it is 
important to know whether recovery is poor because there is no neuronal replacement, or 
whether recovery is poor despite neuronal replacement. The answer to this question will 
guide our thinking about future strategies to improve functional recovery with cell therapy.  
Radiocarbon dating can be used to estimate the turnover dynamics of a cell population (196). 
In a previous study from our group, radiocarbon dating of cortical neurons from stroke 
survivors showed that there is no stroke-induced neurogenesis in this brain region (133). 
However, the striatum may be different, as there is adult neurogenesis here already in the 
healthy human brain (109). In Paper III, we used radiocarbon dating to assess whether stroke 
leads to an increase in striatal neurogenesis in humans. 
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Results from the radiocarbon dating analysis showed that there is indeed a higher proportion 
of young neurons in the stroke-injured striatum, compared to the non-injured control striatum 
of the same patients. This is suggestive of neurogenesis but is also compatible with selective 
death of the oldest neurons, a scenario possible only in brain regions with lifelong adult 
neurogenesis, like the striatum. Mathematical modeling indicated that even if old neurons 
would be 10% more likely to die than young ones, the high neuronal 14C values of some 
subjects were best explained by stroke-induced neurogenesis. 
In the healthy human striatum, neuronal turnover is restricted to interneurons (109). In 
subsequent histology analyses, we therefore quantified the proportion of interneurons in the 
stroke-injured striatum. In addition, we assessed the proportion of neurons containing the age 
pigment lipofuscin, as a proxy for cell age. Both of these analyses indicated that there is an 
increased proportion of young neurons in the stroke-injured striatum. However, neither 
analysis could discriminate between neurogenesis and selective death of old neurons. 
 
6.4.2 Discussion (Paper III) 
Our results show that stroke leads to an increased proportion of young neurons in the stroke-
injured human striatum. However, these results could in theory be explained by one of two 
different scenarios: stroke-induced neurogenesis or selective death of old neurons. This issue 
might be resolved by analyzing more subjects that died very shortly after their stroke. This is 
because any selective neuronal death would likely occur immediately during stroke, whereas 
a population of newborn neurons would take months or years to accumulate. Therefore, 
subjects in which any putative selective neuronal death had occurred, but not much 
neurogenesis, would allow an estimation of the extent of selective neuronal death. 
Interestingly, one such subject already existed in our dataset, and their 14C values were 
tantalizing: This individual was the only one who did not show an increased proportion of 
young neurons in their stroke-injured striatum. If anything, this subject showed an increased 
proportion of old neurons, suggesting selective death of young neurons. Such a selective 
death of young neurons would fit well with a previous radiocarbon dating study that showed 
that Huntington’s disease causes selective death of adult-born neurons rather than the oldest 
neurons (109). In the current study, the results from this one subject therefore suggest that 
any putative selective death of old neurons is not great enough to cause a detectable increase 
in neuronal 14C concentration. Instead, the increased 14C concentration in the stroke-injured 
striatum observed in all other subjects could therefore be best explained by neurogenesis. It 
will be of great importance to analyze more such subjects. 
One conclusion we can draw with certainty from our data is that the proportion of young 
interneurons is increased in the stroke-injured striatum compared to the healthy striatum. It is 
not known what the functional consequence of this is, but it is likely to be of some relevance 
as interneurons and projection neurons have different roles in sculpting neuronal circuits. 
  47 
Recovery is often poor in stroke patients, and it is important to know whether this is due to a 
total lack of neuronal replacement or despite some neuronal replacement. The reason this is 
important is that such knowledge may guide future strategies to improve stroke recovery 
through artificially induced neuronal replacement. If there is already some stroke-induced 
neurogenesis in the brain, this means that the brain has mechanisms in place to generate new 
neurons and that this process might be boosted. On the other hand, it would mean that stroke 
recovery is poor despite stroke-induced neurogenesis, which might limit the usefulness of 
neuronal replacement as a therapeutic strategy. If it turns out that there is no stroke-induced 
neurogenesis at all, it is harder to envision how to achieve therapeutic neuronal replacement, 
as there would be no naturally occurring process that could be boosted. On the other hand, if 
there is no neuronal replacement taking place naturally, chances are that adding just a few 
artificially may have a large beneficial impact. 
What might be the origin of any stroke-induced striatal neurons? As discussed extensively in 
this thesis, striatal astrocytes of mice can activate a neurogenic program in response to stroke. 
Could the same be true of human striatal astrocytes? Much of what we know about astrocytes 
comes from studies in rodents, even though it is known that human astrocytes look very 
different and are more diverse than those in mice and rats. One study that compared the 
genomes of brain cells in humans and mice suggested that it was in fact among glial 
transcripts that the biggest species differences existed between the two species (210). Human 
astrocytes occupy a volume 17 times as large as that of mouse astrocytes, project ten times as 
many GFAP+ filaments and have more diverse shapes (211). They might even be superior to 
mouse astrocytes in the way they regulate neuronal signaling. Incredibly, one research group 
transplanted human glial progenitor cells to the developing mouse brain and showed that the 
adult mice, now having human astrocytes in their brains, displayed increased cognitive 
capacity (212).  
Whether human and rodent astrocytes differ in their intrinsic capacity to generate neurons is 
not known. Some studies have reported that cells can be isolated from the human cortex and 
form neurons in vitro if stimulated with growth factors (213, 214), though the identity of 
these neurogenic cells was not shown. Other studies, in contrast, report that no such cells can 
be isolated from the human brain (215, 216). These opposing results might possibly be 
explained by different culturing protocols or postmortem time. In the near future, one of the 
most pressing questions in the field will be to characterize the neurogenic potential of human 
astrocytes. 
What would be the mechanism by which new neurons benefit the injured brain? The most 
obvious answer is that each new neuron would take the exact place of one dead neuron, such 
that all neuronal subtypes and their connections were restored. Although it is possible to 
imagine a scenario where we are able to regenerate all neuronal subtypes at correct 
proportions, perfect neuronal replacement will likely be extremely difficult to achieve. One 
reason for this was discussed above, namely that the tissue patterning signals that guided 
neural connectivity during development are no longer present in the adult. Therefore, new 
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neurons could probably not re-establish long-range neuronal connections. Even salamanders, 
the masters of regeneration among the vertebrates, cannot re-establish long-range neural 
connections after injury (54), probably for a lack of patterning signals. Another reason why 
perfect neuronal replacement is not likely to be achieved in the near future is that brain injury 
leads to massive scarring and tissue remodeling. Only adding neurons will not restore a lesion 
site to its original condition. Rather, biological engineering on a scale and precision only 
dreamed of today would likely be needed to revert an injury-remodeled tissue to its former 
state. For these reasons, any beneficial effect of new neurons would likely be of a different 
kind. 
One scenario is that new neurons act as relays that reconnect two spared neurons that used to 
be directly connected to one another. This has been demonstrated in one study of spinal cord 
injury in rats. Here, neural stem cells grafted to the lesion site developed into neurons that 
received connections from endogenous descending motor neurons and in turn projected their 
own axons to distal targets (217).  
A second scenario is that new neurons are used only as a source for the neurotransmitters 
they secrete. This is the case with strategies to replace dopamine-producing neurons in 
Parkinson’s disease patients. In experimental and clinical studies, dopaminergic neurons have 
been transplanted to the striatum, which is the region where dopamine is needed, but not 
where dopaminergic neurons are normally located. This seems not to matter, however, as 
transplanted neurons can secrete dopamine and re-establish striatal circuit function (72). 
A third scenario is to generate interneurons that tune and modulate spared neuronal circuits. 
Interneurons make up only 10-15% of all neurons in the rodent brain (218), but despite their 
scarcity, they have a huge impact on neuronal circuit output. This is because they can 
modulate and coordinate the firing pattern of surrounding neurons (219). Furthermore, their 
impact on a circuit is not only determined by their numbers; rather, individual interneurons 
can tune the strength of their inhibitory signals onto surrounding neurons (220). This suggests 
that individual interneurons change their output strength to match the need of their local 
circuit, potentially giving each interneuron very large influence over the circuitry. In turn, this 
suggests that functionally significant effects on brain recovery may be achieved if only a 
small amount of new interneurons could be generated. Indeed, as described below, the small 
number of neurons generated in response to stroke in the rodent striatum are mostly 
interneurons (112, 122), suggesting that interneuron generation may be the actual “strategy” 
used by the injured brain to sculpt spared neuronal circuits. 
As a side note, it is interesting to speculate whether cognitive performance of the healthy 
brain, too, would be improved by adding more neurons. After all, cognitive capacity appears 
to be positively correlated with neuronal density: Comparisons between species show that 
primates, who have comparatively high cognitive capacity, have brains particularly densely 
packed with neurons. For example, the brain of the capuchin monkey contains more than 
twice as many neurons as the similar-sized brain of the capybara, a large rodent (221). One 
idea, then, is that neuronal density is causally correlated with cognitive capacity and that we 
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could in effect become “smarter” by increasing our neuronal density even further. This may 
be the case; the answer is not known. However, species comparisons within primates show 
that the human brain’s neuronal density is not higher than that of other primates. Our brains 
are simply bigger than those of other primates and therefore have more neurons (221). To 
understand whether the healthy brain’s cognitive capacity could be improved with greater 
numbers of neurons, it may also be instructive to study the developing brain, where neuronal 
numbers are precisely tuned. During brain development, more neurons are generated than are 
needed, but in early postnatal life roughly half of all neurons die, through mechanisms that 
are not fully understood (220, 222). In one study, immature interneurons were transplanted to 
the postnatal mouse brain in an attempt to increase the number of neurons (220). Though 
many of these transplanted neurons died, it was possible to increase the total number of 
interneurons in the brain by up to 35%. Interestingly, even though the role of interneurons is 
to inhibit surrounding projection neurons, there was no increase in neuronal inhibition as a 
result of the more abundant interneurons. This means that individual interneurons tuned the 
strength of their inhibitory signals to compensate for their higher numbers, such that the 
performance of the circuit was optimized. By analogy, then, these results suggest that adding 
more neurons to the healthy adult brain would not lead to an improved computing power of 
neural circuits. Rather, homeostatic mechanisms would act to maintain circuit performance in 
its ground state.  
 
6.5 PAPER IV 
6.5.1 Summary of results 
Analysis of gene expression in histological tissue sections is a cornerstone of biomedical 
research. With methods like in situ hybridization, it is possible to study how gene expression 
differs between regions in a tissue. With this method, however, analysis is usually limited to 
one single gene at a time (though newer variants allow the detection of hundreds of genes at a 
time (223)). In contrast, recently developed methods like single-cell RNA sequencing enable 
the detection of practically the entire transcriptome in a single experiment. Here, however, 
information about each cell’s position in the tissue is lost. There has been a lack of methods 
for analyzing the entire transcriptome and simultaneously retain information about the spatial 
expression pattern of genes. 
In Paper IV, we developed spatial transcriptomics, a technology that addresses this issue. 
Here, an intact tissue section is placed onto a chip and treated such that cellular RNA leaks 
out to the surface of the chip. The chip’s surface is covered with DNA oligonucleotide 
probes. These bind to the RNA and additionally contain barcode sequences unique to each 
probe’s position on the chip. By sequencing the probes with the captured RNA, 
transcriptional information is retrieved and each transcript’s spatial information can be 
reconstructed. 
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We first applied this method to the mouse olfactory bulb, a structure whose distinct spatial 
features make it suitable for proof-of-concept implementation. Initial tests showed that a 
permeabilized tissue section releases RNA onto the chip with minimal sideways leakage, the 
hybridized RNA generating a near-perfect spatial representation of the tissue’s cells on the 
chip. After sequencing, we measured the sensitivity of transcript detection to be on the lower 
end of the sensitivity span reported for single-cell RNA sequencing. Compared to the gold 
standard (single-molecule fluorescent in situ hybridization [smFISH]), spatial transcriptomics 
detected 0.069 times as many transcripts. 
Each region in the olfactory bulb generated sequencing data that matched the known cell 
types in that region. An unbiased dimensionality reduction analysis (tSNE) of all sequencing 
data was able to distinguish each region computationally. These results showed that spatial 
transcriptomics works and can be used to ask biologically relevant questions about spatial 
differences in gene expression. 
Finally, we asked whether spatial transcriptomics could generate clinically valuable 
information in cancer diagnostics. We therefore analyzed a human breast cancer biopsy that 
contained regions of invasive ductal cancer and cancer in situ. We found that the invasive 
component expressed high levels of extracellular matrix-associated genes. The six cancer-in-
situ regions were surprisingly heterogeneous, suggesting that the biopsy contained multiple 
individual cancer clones evolving in parallel. This information would not have been available 
with regular cancer diagnostic tools or sequencing technology. 
 
6.5.2 Discussion (Paper IV) 
RNA sequencing is very useful for classifying, cataloging and characterizing the cell types 
that exist in the body. The method presented in Paper IV introduces a new dimension to gene 
expression analysis because of its spatial aspect. Using this technique, distinct cell types and 
states that are detected can be placed in their right spatial context, adding very useful 
information to the analysis. 
The resolution of spatial transcriptomics depends on the size and distribution of barcode-
coated features arrayed on the chip. Currently, each such feature is 100 µm in diameter, and 
the center-to-center distance of neighboring features is 200 µm. This means that the current 
version of spatial transcriptomics does not have single-cell resolution and that there are areas 
between the features where RNA is not captured. 
The detection limit of transcripts is on the lower end of that reported for single-cell RNA 
sequencing, detecting 6.9% of the number of transcripts smFISH detected from a control 
sample. Together with the fact that average sequencing read length was around 300-600 
nucleotides, this means spatial transcriptomics is currently most suitable to detect spatial 
differences in transcripts expressed at medium to high levels and that it is suitable for 
analyses that do not require full-length transcripts. 
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Taken together, the spatial dimension introduced by spatial transcriptomics makes it a 
powerful tool, useful both basic research and clinical diagnostics. Current limitations to the 
method’s spatial resolution and sequencing depth make the method suitable for studying clear 
transcriptional differences between broad spatial regions. 
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